UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: September 30, 2016

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________________ to ____________________.

Commission file number: 000-50053

AMERITYRE CORPORATION

(Exact name of small business issuer as specified in its charter)

NEVADA	87-0535207
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

1501 Industrial Rd., Boulder City, NV	89005
(Address of principal executive offices)	(Zip Code)

(702) 293-1930

(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ý

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ý

The number of shares outstanding of Registrant’s Common Stock as of November 4, 2016: 42,325,287

TABLE OF CONTENTS

		Page
PART I
Item 1.	Financial Statements	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operation	11
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	18
Item 4.	Controls and Procedures	18
PART II
Item 1.	Legal Proceedings	19
Item 1A.	Risk Factors	19
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	19
Item 3.	Defaults Upon Senior Securities	19
Item 4.	Not Applicable	19
Item 5.	Other Information	19
Item 6.	Exhibits	19

SIGNATURES		20

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

AMERITYRE CORPORATION

Balance Sheets

	September 30, 2016			June 30, 2016
	(Unaudited)
ASSETS
CURRENT ASSETS
Cash	$	201,470		$	267,302
Accounts receivable - net		372,492			293,358
Inventory - net		625,072			614,895
Prepaid and other current assets		74,475			103,803
Total Current Assets		1,273,509			1,279,358

PROPERTY AND EQUIPMENT
Leasehold improvements		196,223			153,543
Molds and models		577,549			577,549
Equipment		2,988,844			2,960,246
Furniture and fixtures		74,921			74,921
Construction in progress		39,593			10,198
Software		305,924			305,924
Less - accumulated depreciation		(3,869,113	)		(3,849,937	)
Total Property and Equipment		313,941			232,444

OTHER ASSETS
Patents and trademarks - net		168,555			175,379
Non-current inventory		185,260			180,050
Deposits		11,000			11,000
Total Other Assets		364,815			366,429
TOTAL ASSETS	$	1,952,265		$	1,878,231

LIABILITIES AND STOCKHOLDER’S EQUITY
CURRENT LIABILITIES
Accounts payable and accrued expenses	$	439,600		$	348,499
Current portion of long-term debt		18,656			20,518
Current portion of lease liability		6,578			6,249
Total Current Liabilities		464,834			375,266
LONG-TERM LIABILITIES
Long-term debt		138,139			100,142
Long-term lease liability		6,621			8,394
Total Long Term Liability		144,760			108,536
Total Liabilities		609,594			483,802

STOCKHOLDERS’ EQUITY
Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively		2,000			2,000
Common Stock: 75,000,000 shares authorized of $0.001 par value, 42,325,287 and 42,175,287 shares issued and outstanding, respectively		42,325			42,175
Additional paid-in capital		62,591,976			62,579,558
Stock payable		-			4,500
Accumulated deficit		(61,293,630	)		(61,233,804	)
Total Stockholders’ Equity		1,342,671			1,394,429
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,952,265		$	1,878,231

The accompanying notes are an integral part of these financial statements.

Table of Contents

AMERITYRE CORPORATION

Statements of Operations

(Unaudited)

	For the Three Months Ended September 30,
	2016			2015

NET SALES	$	836,153		$	1,013,933

COST OF REVENUES		555,452			766,776

GROSS PROFIT		280,701			247,157

EXPENSES
Research and development		52,859			53,605
Sales and marketing		67,230			97,664
General and administrative		192,306			224,840

Total Expenses		312,395			376,109

LOSS FROM OPERATIONS		(31,694	)		(128,952	)

OTHER (EXPENSE)/INCOME
Interest income		53			73
Interest expense		(3,185	)		(599	)

Total Other (Expense)/Income		(3,132	)		(526	)

NET LOSS		(34,826	)		(129,478	)

Preferred Stock Dividend		(25,000	)		(25,000	)

NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$	(59,826	)	$	(154,478	)

BASIC AND DILUTED LOSS PER SHARE	$	(0.00	)	$	(0.00	)

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING		42,302,461			41,631,157

The accompanying notes are an integral part of these financial statements.

Table of Contents

AMERITYRE CORPORATION

Statements of Cash Flows

(Unaudited)

	For the Three Months Ended September 30,
	2016			2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$	(34,826	)	$	(129,478	)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization expense		26,000			39,508
Change in allowance for bad debt expense (recovery)		-			(289	)
Stock based compensation		8,068			10,768
Changes in operating assets and liabilities:
Accounts receivable		(79,134	)		(185,831	)
Prepaid and other current assets		(28,665	)		(36,091	)
Inventory and any change in inventory reserve		(15,387	)		(5,094	)
Accounts payable and accrued expenses		66,101			(2,627	)
Net Cash Used by Operating Activities		(57,843	)		(309,134	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(5,048	)		-
Net Cash Used by Investing Activities		(5,048	)		-
CASH FLOWS FROM FINANCING ACTIVITIES
Payment on lease liability		(1,444	)		(778	)
Payments on notes payable		(1,497	)		(560	)
Preferred stock dividends		-			(25,000	)
Net Cash Used by Financing Activities		(2,941	)		(26,338	)
NET DECREASE IN CASH		(65,832	)		(335,472	)
CASH AT BEGINNING OF PERIOD		267,302			455,717
CASH AT END OF PERIOD	$	201,470		$	120,245

NON-CASH FINANCING ACTIVITIES
Interest paid		3,185		599
Income taxes paid		-		-

SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES

Capitalized lease	$	-	$	19,337
Write off of previous reserved forklift tires	$	81,224	$	-
Purchase of fixed assets through debt	$	95,625	$	-
Accrued preferred stock dividends	$	25,000	$	-
Issuance of stock for stock payable	$	4,500	$	-

The accompanying notes are an integral part of these financial statements.

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2016

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. We believe the disclosures and information presented are adequate to make the information not misleading. These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K. Operating results for the quarter ended September 30, 2016 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2016.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K, except as noted below.

Reclassifications

Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of “store” inventory as part of other current assets at September 30, 2015.

Basic and Fully Diluted Net Loss Per Share

Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.

Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation. We excluded 3,800,000 and 3,370,000 common stock equivalents for the quarters ended September 30, 2016 and 2015, respectively, because they are anti-dilutive.

Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Issued

In August, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)” ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.

NOTE 3 - INVENTORY

	September 30, 2016			June 30, 2016
	(Unaudited)
Raw Materials	$	228,232		$	257,260
Finished Goods		628,957			663,666
Inventory reserve		(46,856	)		(125,981	)
Inventory – net (current and long term)	$	810,333		$	794,945

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2016

Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.

In fiscal years 2017 and 2016, the Company critically reviewed all slow moving inventory to determine if defective or obsolete. If not defective or obsolete we presented these items as non-current inventory, although all inventory is ready and available for sale at any moment.

For those items that are spare maintenance materials or parts kept on hand as backup components of major production lines, or “store inventories”, the Company capitalizes the amount if above our capitalization policy for property and equipment. In the past we have included these items as part of our raw materials inventory. As of September 30, 2015 these items, amounting to $10,815, have been reclassified into other current assets.

NOTE 4 – DEBT

A former board member, Silas O. Kines, who passed away on January 11, 2012, was also the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc. In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales. In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long term liability recorded on the transaction. As of September 30, 2016, $2,000 and $63,425 (June 30, 2016, $11,752 and $53,840) were recorded for the current and long-term portion, respectively, of the related liability.

In June 2016, the Company executed a term note with U.S. Bank to finance critical manufacturing equipment and operating enhancements. Manufacturing equipment of approximately $29,000 was place in service in July 2016. The remaining operating enhancements are expected to be in service at the end of the second quarter of fiscal 2017. Total amount financed was $55,068, at 5.59% interest, with payments of $1,059 due for 60 months starting July 2016.

In July 2016, the Company executed a term note with U.S. Bank to finance critical plant facility equipment which was placed into service in July 2017. The total amount financed was $37,666 at 5.59% interest, with payments of $720 due for 60 months starting October 2016.

	Payments due by period
	Total			Less than 1 year		1 to 3 years		3 to 5 years		After 5 years

Bank debt (both US Bank facilities above)		$	91,384	$	16,656	$	59,726	$	15,001	$	-

Total cash obligations		$	91,384	$	16,656	$	59,726	$	15,001	$	-

NOTE 5 - CAPITAL LEASE

In July 2015 the Company entered into a capital lease for research and development equipment for $19,337 (which has accumulated depreciation of $4,673).

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of September 30, 2016:

2017	$	6,523
2018		8,697
2019		725
2020		-
2021		-
Total minimum lease payments		15,945
Less: executory costs		-
Net minimum lease payments		15,945
Less: amount representing interest		2,761
Present value of net minimum payments	$	13,184

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2016

NOTE 6 - STOCK OPTIONS AND WARRANTS

Prior Issuances of options

On December 1, 2015, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer. The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020.

On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the Board term ending December 2016. The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019.

On January 19, 2016, 50,000 options were granted to the Company’s Chief Financial Officer as part of renewal of her employment agreement. The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019. In addition to the option renewal $550 a month in health insurance reimbursement was included in the renewal. All other terms remain the same.

Year to date expense related to these options is $8,068 as of September 30, 2016.

A summary of the status of our outstanding stock options as of September 30, 2016 and June 30, 2016 and changes during the periods then ended is presented below:

The following table summarizes the range of outstanding and exercisable options as of September 30, 2016:

	September 30, 2016							June 30, 2016
			Weight Average		Intrinsic					Weight Average		Intrinsic
	Shares		Exercise Price		Value			Shares		Exercise Price		Value
Outstanding beginning of period		3,800,000	$	0.13					2,270,000	$	0.14
Granted		-	$	0.00					1,530,000	$	0.10
Expired/Cancelled		-	$	0.00					-	$	0.00
Exercised		-	$	0.00					-	$	0.00
Outstanding end of period		3,800,000	$	0.13		$	-		3,800,000	$	0.13		$	-
Exercisable		3,195,000	$	0.13		$	-		3,070 ,000	$	0.13		$	-

		Outstanding						Exercisable
Range of Exercise Prices		Number Outstanding at September 30, 2016		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable at September 30, 2016		Weighted Average Remaining Contractual Life
$	0.08		150,000		5.17	$	0.08		150,000		5.17
$	0.10		2,200,000		2.59	$	0.10		1,595,000		2.59
$	0.17		1,450,000		4.17	$	0.17		1,450,000		4.17
			3,800,000						3,195,000

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2016

NOTE 6 - STOCK OPTIONS AND WARRANTS (CONTINUED)

General Warrant Information

In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010. This note was paid off as of June 30, 2015. In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees. The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share. As of September 30, 2016 the warrants expired.

NOTE 7 - LIQUIDITY

Our principal sources of liquidity consist of cash and payments received from our customers. We do not have any significant revolving credit arrangements. Historically, our expenses have exceeded our sales, resulting in operating losses. From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments. At the end of 2016 and early 2017, we were able to obtain term bank debt financing to finance critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017. Management continues to evaluate financing options but is choosing to delay financing at terms that will subject the Company to high costs of debt and are reluctant to raise money through stock sales at what we believe are highly dilutive share prices. Additionally, management has notified our preferred shareholder that we will be suspending future payments of their preferred cash dividend payments, so the Company can increase its working capital levels.

We have been working during the past year to improve our liquidity and access to capital resources. In order to execute the strategic business plan discussed during our shareholder meeting in December 2015, we require more capital resources. We will continue to pursue potential opportunities to secure short-term loans, long-term bank financing, revolving lines of credit with banking institutions and equity based transactions with interested financial firms and strategic industry partners in our effort to improve the Company’s financial position and enhance shareholder value.

Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments. The Company currently does not have an existing revolving credit facility. In June and July 2016, in two separate bank promissory notes, we financed critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017. Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.

We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to that required to maintain current manufacturing capability or support business initiatives identified in our strategic sales plan. We continue to work to reduce our overall costs wherever possible.

To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit. Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices. This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

Management continues to execute its strategic plan focusing on “Profitability as a Mindset”. The Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales. Improvement in results has continued and the Company has been successful in reducing its required breakeven sales level. We believe our program to establish “Profitability as a Mindset” is a success and we are committed to continuing these efforts.

Table of Contents

AMERITYRE CORPORATION

Notes to the Unaudited Financial Statements

September 30, 2016

NOTE 7 – LIQUIDITY (CONTINUED)

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations. In connection with the preparation of our financial statements for the period ended September 30, 2016, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period. However, to expand manufacturing and sales operations beyond the current level, additional capital may be required.

The Company has, on occasion, instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be selectively utilized in the upcoming quarters to monetize inventory and improve our cash flow.

As of November 4, 2016 the Company has approximately 7,488,713 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition. Such statements are only predictions and the actual events or results may differ materially from the results discussed in or implied by the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in “Part I. Item 1A. Risk Factors” as well as those discussed elsewhere in this report. The historical results set forth in this discussion and analyses are not necessarily indicative of trends with respect to any actual or projected future financial performance. This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.

Overview

Amerityre engages in the research and development, manufacturing and sale of polyurethane tires. We believe that we have developed unique polyurethane formulations that allow us to make products with superior performance characteristics, including abrasion resistance, energy efficiency and load-bearing capabilities, when compared to conventional rubber tires. We also believe that our manufacturing processes are more energy efficient than the traditional rubber tire manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps, extreme heat, and high pressure that are necessary to cure rubber. Using our polyurethane technologies, we believe tires can be produced which last longer, are less susceptible to failure and are friendly to the environment.

We are concentrating on three segments of the tire market: closed-cell polyurethane foam tires, polyurethane elastomer tires and agricultural tires. Our focus continues to be applications and markets where our advantages in product technology give us an opportunity to provide unique products and obtain premium pricing. Our most recent activities in these areas are set forth below:

Closed-Cell Polyurethane Tires – The sale of polyurethane foam tires to original equipment manufacturers, distributors and dealers accounts for the majority of our revenue. We have the ability to produce a broad range of products for the light duty tire market. Our efforts in product development and marketing allow us to continue to build customer relationships and expand sales with original equipment manufacturers and tire distributors. We continue our focus on creating unique product solutions for customers with specific tire performance requirements. Some of our international customers have had reduced sales levels over the year, negatively impacted by the strong US dollar exchange rate versus foreign currencies.

Polyurethane Elastomer Tires – During the fourth quarter of FY 2016 we relaunched the forklift tire product line with select customers. The rollout has been slower than expected and we await feedback from these initial customers on their satisfaction with our forklift tires before committing resources to a larger rollout campaign. We are also developing new elastomer tire products for specific customer applications, such as scissor lift tires. We expect sales in this market segment to increase in the coming quarters as these new products are introduced and gain market acceptance.

Agricultural Tires – Sales of agricultural tires continue to be negatively impacted by the dramatic downturn in farm commodity prices, which has in turn reduced farm income levels and available money for investment in farm equipment. Recent projections of crop yield and prices for this year indicate that farm income will continue to suffer in the coming months. Large agricultural equipment suppliers continue to expect 2017 to be a challenging year for farmer income and farm-related spending. Despite growing market acceptance of the benefits of our pivot tire and seeder tire technologies, financial considerations have continued to force potential agricultural tire customers to delay purchases. Given this backdrop, we are not anticipating dramatic agricultural sales gains for FY 2017 compared to FY 2016. We continue to pursue additional distribution relationships, both domestically and internationally, to increase our market penetration for our agricultural tires. We have found that the strength of the US Dollar versus other foreign currencies has negatively impacted our international business. We expect that exchange rate effects will continue to dampen our international sales efforts in the coming quarters. We have continued development of new seeder tire styles in response to specific customer requirements, and we expect this will help drive additional sales in this product line.

Due to the Company’s limited resources, tire projects which are contingent on additional significant development, such as composite and automotive tires, have been put on hold and will be revisited at a later date.

Table of Contents

As described above, our product line covers diverse market segments which are unrelated in terms of customer base, product, distribution, market demands and competition. Our sales team is comprised of three independent manufacturer representatives whose experience is complementary to our product portfolio plus our in-house sales department. The Company’s emphasis on proper product pricing and new marketing campaigns continues to drive more profitable sales, as shown by our profitable FY 2016 third and fourth quarter results, as well as dramatically reducing the net loss for Q1 FY 2017 compared to the results of Q1 FY 2016. We continue to look for ways to reduce manufacturing costs to improve gross margins in the face of this difficult economic conditions in our target markets. Nevertheless, we have a solid backlog of orders for closed cell foam product to be delivered over the next 12 months, but we expect that the challenging economic environment, particularly in the agricultural market, will continue to provide strong headwinds and negatively impact our drive towards consistent and increasing profitability.

During our Annual Meeting in December 2015, the Company’s Senior Management outlined its strategic plan for increasing the Company’s sales, profitability, and market awareness. At that time Management expressed the need for additional working capital in order to execute its plan in a timely manner. In the absence of additional capital, it was stated that any initiatives would need to be paid from internally generated cash flow. During the fiscal Q4, the Company was successful in procuring a term loan to finance needed investments in manufacturing equipment, laboratory instruments, and website development. However, a lack of available capital prevented the Company from executing its other strategic marketing initiatives, which we believe has negatively impacted the Company’s market position and profitability. Without additional capital in FY 2017, the implementation of the Company’s strategic plan will be delayed unless initiatives can be financed out of internally generated cash flow.

Factors Affecting Results of Operations

Our operating expenses consisted primarily of the following:

·	Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

·	Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

·	Research and development expenses, which consist primarily of contractor and direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

·	Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

·	Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

·	Stock based compensation expense related to stock and stock option awards issued to employees and consultants for services performed for the Company.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies. We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances. These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

We believe the following accounting policies are our critical accounting policies because they are important to the portrayal of our financial condition and results of operations and they require critical management judgments and estimates about matters that may be uncertain. If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.

Revenue Recognition

Revenue for products is recognized when the sales amount is determined, shipment of goods to the customer has occurred and collection is reasonably assured. Generally, we ship all of our products FOB origination.

Table of Contents

Valuation of Intangible Assets and Goodwill

Patent and trademark costs have been capitalized at September 30, 2016, totaling $479,633 with accumulated amortization of $311,078 for a net book value of $168,555. Patent and trademark costs capitalized at September 30, 2015, totaled $479,633 with accumulated amortization of $304,254 for a net book value of $175,379.

The patents which have been granted are being amortized over a period of 20 years. Patents which are pending or are being developed are not amortized. Amortization begins once the patents have been issued. As of September 30, 2016 and 2015, respectively, there were no pending patents. Annually, pending or expired patents are inventoried and analyzed, which resulted in the recognition of a loss on abandonment, expiration or retirement of patents and trademarks of $-0- for each of the years ended September 30, 2016 and 2015, respectively.

Amortization expense for the years ended September 30, 2016 and 2015 was $6,824 and $6,834 respectively. The Company evaluates the recoverability of intangibles and reviews the amortization period on a continual basis utilizing the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, Intangibles – Goodwill and Other. We consider the following indicators, among others, when determining whether or not our patents are impaired:

·	any changes in the market relating to the patents that would decrease the life of the asset;

·	any adverse change in the extent or manner in which the patents are being used;

·	any significant adverse change in legal factors relating to the use of the patents;

·	current period operating or cash flow loss combined with our history of operating or cash flow losses;

·	future cash flow values based on the expectation of commercialization through licensing; and

·	current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.

Inventory

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market. The cost of finished goods includes the cost of raw material, direct and indirect labor, and other indirect manufacturing costs. The inventory consists of chemicals, finished goods produced in the Company’s plant and products purchased for resale.

Financial and Derivative Instruments

The Company periodically enters into financial instruments. Upon entry, each instrument is reviewed for debt or equity treatment. In the event that the debt or equity treatment is not readily apparent, FASB ASC 480-10-S99 is consulted for temporary treatment. Once an event takes place that removes the temporary element the Company appropriately reclassifies the instrument to debt or equity.

The Company periodically assesses its financial and equity instruments to determine if they require derivative accounting. Instruments which may potentially require derivative accounting are conversion features of debt, equity, and common stock equivalents in excess of available authorized common shares, and contracts with variable share settlements. In the event of derivative treatment, we mark the instrument to market.

Stock-Based Compensation

We account for stock-based compensation under the provisions of FASB ASC 718, Compensation – Stock Compensation. Our financial statements as of and for the fiscal years ended September 30, 2016 and 2015 reflect the impact of FASB ASC 718. Stock-based compensation expense recognized under FASB ASC 718 for the fiscal years ended September 30, 2016 and 2015 was $8,068 and $10,768, respectively, related to employee stock options and employee stock grants.

FASB ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations. Stock-based compensation expense recognized in our Statements of Operations for fiscal years ended September 30, 2016 and 2015 assume all awards will vest; therefore no reduction has been made for estimated forfeitures.

Table of Contents

Results of Operations

Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows. These key performance indicators include:

·	Sales consisting of product sales;

·	Sales, net of returns and trade discounts, which is an indicator of our overall business growth and the success of our sales and marketing efforts;

·	Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;

·	Growth in our customer base, which is an indicator of the success of our sales efforts; and

·	Distribution of sales across our products offered.

The following summary table presents a comparison of our results of operations for the fiscal quarters ended September 30, 2016 and 2015 with respect to certain key financial measures. The comparisons illustrated in the table are discussed in greater detail below.

	Three Month Period Ended September 30,						Percent Change
	(in 000’s)
	2016			2015			2016 vs. 2015
Net revenues	$	836		$	1,014			(17.6	)%
Cost of revenues		(555	)		(767	)		(27.6	)%
Gross profit		281			247			13.8	%
Research and development expenses		(53	)		(54	)		(1.9	)%
Sales and marketing expense		(67	)		(98	)		(31.6	)%
General and administrative expense		(192	)		(224	)		(14.7	)%
Other income (expense)		(3	)		(1	)		200.0	%
Net loss		(34	)		(130	)		(74.6	)%
Preferred stock dividend		(25	)		(25	)		0.0	%
Net loss attributable to common shareholders	$	(59	)	$	(155	)		(62.6	)%

Quarter Ended September 30, 2016 Compared to September 30, 2015

As disclosed in our June 30, 2016 Annual Report on Form 10-K, the first quarter of each of our fiscal years has traditionally been our weakest quarter. The primary driver for this weakness in Q1 FY 2017 is much lower pivot tire sales as well as reduced sales of closed cell foam products during the quarter. A major order that was due to ship during the last week of the quarter was delayed one week at the customer’s request, and this accounted for approximately half of the revenue shortfall of the quarter versus year ago results. We expect continued weakness in the agricultural business segment throughout the remainder of FY 2017.

Net Sales. Net sales of $836,153 for the quarter ended September 30, 2016, represents a 17.6% decrease over net sales of $1,013,933 for the same period in 2015. These results were in line with our expectations as we anticipated that we would not have strong pivot tire sales for the period. Our sales were driven primarily by closed cell foam tire sales. We continue to have a positive response to our marketing and pricing plans for our polyurethane foam tires, which has helped to maintain our sales backlog level. Our forecast for the fiscal 2017 anticipates continued depressed agricultural tire sales, due to the continuation of depressed farm income. We expect our polyurethane foam products to constitute the majority of our sales during the upcoming fiscal year.

Cost of Revenues. Cost of revenues for the quarter ended September 30, 2016 was $555,452 or 66.4% of sales compared to $766,776 or 75.6% of sales for the same period in 2015. Cost of revenues were lower due to decreases in raw materials expenditures and overhead costs partially offset by higher plant wages when compared to the prior period. The Company continues to maintain sufficient production capacity to meet anticipated customer demand without incurring a proportionate increase in overall production costs.

Table of Contents

Gross Profit. Gross profit for the quarter ended September 30, 2016 was $280,701 compared to $247,157 for the same period in 2015. Gross profit for the quarter ended September 30, 2016 increased by $33,544 or 13.8% over the same period in 2015 due to the decrease in cost of revenue outlined in the discussion above. The September 30, 2016 gross profit reflects a 33.6% gross margin for product sales compared to a gross margin on product sales of 24.4% in 2015.

Research & Development Expenses (R&D). Research and development expenses for the quarter ended September 30, 2016 were $52,859 compared to $53,605 for the same period in 2015. Research and development expenses are flat between the periods due to changes made in fiscal year 2016 which we continue to focus on product formulation research and product development. The Company plans to continue this level of expenditure as R&D is a key component of the company new product and business improvement initiatives.

Sales & Marketing Expenses. Sales and marketing expenses for the quarter ended September 30, 2016 were $67,230 as compared to $97,664 for the same period in 2015. Sales and marketing expenses decreased $30,434 between periods primarily due to lower paid commissions and travel costs, offset by increased trade show expenses.

General & Administrative Expenses. General and administrative expenses for the quarter ended September 30, 2016 were $192,306 compared to $224,840 for the same period in 2015. General and administrative expenses decreased $32,534 between periods primarily due to savings in warranty expense and professional fees.

Other Expense. Other expense for the quarter ended September 30, 2016 was $3,185 compared to $599 for the same period in 2015. Other expense consists solely of interest expense and increased due to our new bank debt facilities.

Net Loss. Net loss for the quarter ended September 30, 2016 of $34,826 represents a 74.6% improvement from the net loss for the quarter ended September 30, 2015 of $129,478.

Liquidity and Capital Resources

Our principal sources of liquidity consist of cash and payments received from our customers. We do not have any significant revolving credit arrangements. Historically, our expenses have exceeded our sales, resulting in operating losses. From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments. At the end of fiscal years 2016 and early 2017, we were able to obtain term bank debt financing to finance critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017. Management continues to evaluate financing options but is choosing to delay financing at terms that will subject the Company to high costs of debt and are reluctant to raise money through stock sales at what we believe are highly dilutive share prices. Additionally, management has notified our preferred shareholder that we will be suspending future payments of their preferred cash dividend payments, so the Company can increase its working capital levels.

We have historically not succeeded in establishing favorable revolving short term financing such as lines of credit. In the quarter ended March 31, 2015, we entered into a short term receivable factoring agreement with a third party to sell our receivable invoices. This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed. As of September 30, 2016 we have not needed to activate this financing option due to increased focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.

Cash Flows

The following table sets forth our cash flows for the quarters ended September 30, 2016 and 2015.

	Periods ended Sept. 30,
	(in 000’s)
	2016				2015
Net cash used by operating activities		$	(58	)		$	(309	)
Net cash used in investing activities			(5	)			-
Net cash used by financing activities			(3	)			(26	)
Net decrease in cash during the period		$	(66	)		$	(335	)

Table of Contents

Net Cash Used by Operating Activities. Our primary sources of operating cash during the quarter ended September 30, 2016 came from collections from customers, however, our period end receivables balance increased as we waited for several large customers to remit payment in early October 2016. Our primary use of operating cash was an increase in prepaid and other current assets, specifically related to renewal of insurance policies. Net cash used by operating activities was $57,843 for the quarter ended September 30, 2016 compared to net cash used by operating activities of $309,134 for the same period in 2015.

Non-cash items include depreciation and amortization and stock based compensation. Our net loss was $34,826 for the quarter ended September 30, 2016 compared to a net loss of $129,478 for the same period in 2015. The net loss for the quarter ended September 30, 2016 included non-cash expenses for depreciation and amortization of $26,000 and stock-based compensation of $8,068. As of September 30, 2015, depreciation and amortization was $39,508 and stock-based compensation (both stock issued and options) totaled $10,768.

Net Cash Used by Investing Activities. Net cash used by investing activities was $5,048 for the quarter ended September 30, 2016 and $0 for the same period in 2015. In this quarter we purchased critical facility equipment of which $5,048 was paid in cash the remainder financed through bank financing.

Net Cash Used by Financing Activities. Net cash used by financing activities was $2,941 for the quarter ended September 30, 2016 and $26,338 for the same period in 2015. The primary use of cash for the quarter ended September 30, 2016 was payment toward the capital lease of $1,444 and payment of notes payable of $1,497.

Contractual Obligations and Commitments

The following table summarizes our contractual cash obligations and other commercial commitments at September 30, 2016.

	Payments due by period
	Total			Less than 1 year		1 to 3 years		3 to 5 years		After 5 years

Facility lease (1)		$	516,600	$	136,800	$	379,800	$	-	$	-
Capital lease (2)			15,945		8,697		7,248		-		-
Bank debt (3)			91,384		21,349		59,726		10,309		-
Total contractual cash obligations		$	623,929	$	166,846	$	446,774	$	10,309	$	-

(1)

In May 2015, we negotiated a five (5) year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada. The property consists of a 49,200 square foot building. We currently occupy all 49,200, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres. All other terms and conditions of the building lease remain in effect.

(2)	In July 2015 we entered into a capital lease for research and development equipment for $19,337.

(3)	In June and July 2016, in two separate bank promissory notes, we financed critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017.

Cash Position, Outstanding Indebtedness and Future Capital Requirements

At November 1, 2016, our total cash balance was $183,181, none of which is restricted; accounts receivables was $346,193; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $709,953. Our total indebtedness was $478,016 and includes $221,832 in accounts payable, $88,041 in accrued expenses, $17,303 in current portion of long-term debt, $12,701 in capital lease liability and $138,139 in long-term debt.

Table of Contents

Off-Balance Sheet Arrangements

We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to changes in prevailing market interest rates affecting the return on our investments but do not consider this interest rate market risk exposure to be material to our financial condition or results of operations. We invest primarily in United States Treasury instruments with short-term (less than one year) maturities. The carrying amount of these investments approximates fair value due to the short-term maturities. Under our current policies, we do not use derivative financial instruments, derivative commodity instruments or other financial instruments to manage our exposure to changes in interest rates or commodity prices.

ITEM 4. CONTROLS AND PROCEDURES

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive and Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our Annual Report on Form 10-K for the year ended June 30, 2016.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Our Annual Stockholder’s Meeting is scheduled for 10am, Wednesday, November 30, 2016 at 1501 Industrial Rd., Boulder City, NV 89005.

ITEM 6. EXHIBITS

31.1		Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101 INS		XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101 SCH		XBRL Taxonomy Extension Schema Document

101 CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101 DEF		XBRL Taxonomy Extension Definition Linkbase Document

101 LAB		XBRL Taxonomy Extension Label Linkbase Document

101 PRE		XBRL Taxonomy Extension Presentation Linkbase Document

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: November 4, 2016

AMERITYRE CORPORATION
By:
/s/ Michael F. Sullivan		/s/ Lynda R. Keeton-Cardno
Michael F. Sullivan Chief Executive Officer (Principal Executive Officer)		Lynda R. Keeton-Cardno Chief Financial Officer (Principal Financial and Accounting Officer)

The following table summarizes the range of outstanding and exercisable options as of September 30, 2016: Amerityre Corp --06-30 0000945828 Yes No Smaller Reporting Company No 2017 Q1 P3Y 3070000 0000945828 2016-09-30 0000945828 2016-06-30 0000945828 2016-07-01 2016-09-30 0000945828 2015-07-01 2015-09-30 0000945828 2015-06-30 0000945828 2015-09-30 0000945828 2016-11-04 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-07-01 2016-09-30 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-09-30 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-06-30 0000945828 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-01 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-09-30 0000945828 2015-07-31 0000945828 amty:OptionsGrantedDecember1_2015Member us-gaap:ChiefExecutiveOfficerMember 2015-12-01 2015-12-01 0000945828 amty:OptionsGrantedDecember1_2015Member us-gaap:ChiefExecutiveOfficerMember 2015-12-01 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMemberMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:AuditCommitteeChairMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedOctober2015Member amty:BoardMembersAndAuditoCommitteChairMember 2015-10-01 2015-10-31 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMembersAndAuditoCommitteChairMember 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMembersAndAuditoCommitteChairMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:MinimumMember us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:MaximumMember us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-07-01 2016-09-30 0000945828 us-gaap:ConvertibleDebtMember 2013-09-30 0000945828 us-gaap:ConvertibleDebtMember 2013-09-01 2013-09-30 0000945828 2015-07-01 2016-06-30 0000945828 amty:OptionsAt0.08Member 2016-09-30 0000945828 amty:OptionsAt0.08Member 2016-07-01 2016-09-30 0000945828 amty:OptionsAt0.10Member 2016-09-30 0000945828 amty:OptionsAt0.10Member 2016-07-01 2016-09-30 0000945828 amty:OptionsAt017Member 2016-09-30 0000945828 amty:OptionsAt017Member 2016-07-01 2016-09-30 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael F. Sullivan, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Amerityre Corporation for the three months ended September 30, 2016;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and I have:

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 4, 2016

/s/ Michael F. Sullivan

Michael F. Sullivan

Chief Executive Officer

(Principal Executive Officer)

EX-31.2 3 ex31-2.htm

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lynda R. Keeton-Cardno, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Amerityre Corporation for the three months ended September 30, 2016;

(c) presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on our evaluation; and

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 4, 2016

/s/ Lynda R. Keeton-Cardno

Lynda R. Keeton-Cardno

Chief Financial Officer

(Principal Financial Officer)

EX-32.1 4 ex32-1.htm

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of Amerityre Corporation (the "Company") on Form 10-Q for the three months ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Michael F. Sullivan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Michael F. Sullivan

Michael F. Sullivan

Chief Executive Officer

(Principal Executive Officer)

November 4, 2016

EX-32.2 5 ex32-2.htm

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of Amerityre Corporation (the "Company") on Form 10-Q for the three months ended September 30, 2016, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lynda R. Keeton-Cardno, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Lynda R. Keeton-Cardno

Lynda R. Keeton-Cardno

Chief Financial Officer

(Principal Financial Officer)

November 4, 2016

GRAPHIC 6 image0.jpg begin 644 image0.jpg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end EX-101.CAL 7 amty-20160930_cal.xml XBRL TAXONOMY EXTENSION - CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 amty-20160930_def.xml XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE EX-101.LAB 9 amty-20160930_lab.xml XBRL TAXONOMY EXTENSION - LABEL LINKBASE Statement of Financial Position [Abstract] Cash CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD Accounts receivable - net Inventory - net Prepaid and other current assets Total Current Assets Leasehold improvements Molds and models Equipment Furniture and fixtures Construction in progress Software Less - accumulated depreciation Total Property and Equipment Patents and trademarks - net Non-current inventory Deposits Total Other Assets TOTAL ASSETS Accounts payable and accrued expenses Current portion of long-term debt Long-term Debt, Current Maturities Current portion of lease liability Total Current Liabilities Long-term lease liability Total Long Term Liability Total Liabilities Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively Preferred stock par value (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common Stock: 75,000,000 shares authorized of $0.001 par value, 42,325,287 and 42,175,287 shares issued and outstanding, respectively Common stock par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Additional paid-in capital Stock payable Accumulated deficit Total Stockholders’ Equity TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Income Statement [Abstract] GROSS PROFIT Research and development Sales and marketing General and administrative Total Expenses LOSS FROM OPERATIONS Interest income Interest expense Total Other (Expense)/Income NET LOSS Net loss Preferred Stock Dividend NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS BASIC AND DILUTED LOSS PER SHARE (in Dollars per share) WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in Shares) Statement of Cash Flows [Abstract] Depreciation and amortization expense Change in allowance for bad debt expense (recovery) Stock based compensation Accounts receivable Prepaid and other current assets Inventory and any change in inventory reserve Net Cash Used by Operating Activities Purchase of property and equipment Net Cash Used by Investing Activities Payment on lease liability Payments on notes payable Preferred stock dividends Net Cash Used by Financing Activities NET DECREASE IN CASH Interest paid Interest Paid Income taxes paid Capitalized lease Write off of previous reserved forklift tires Purchase of fixed assets through debt Accrued preferred stock dividends Issuance of stock for stock payable Disclosure Text Block [Abstract] Accounting Policies [Abstract] Inventory Disclosure [Abstract] Schedule of Inventory [Abstract] Inventory – net (current and long term) Debt Disclosure [Abstract] Schedule of Maturities of Long-term Debt [Abstract] Long-term Debt, Type [Axis] Notes Payable to Banks [Member] Disclosure Text Block Supplement [Abstract] Schedule of Capital Leased Assets [Abstract] 2021 Total minimum lease payments Capital Leases, Future Minimum Payments Due Less: executory costs Net minimum lease payments Less: amount representing interest Present value of net minimum payments Schedule of Share-based Compensation, Stock Options, Activity [Abstract] Outstanding beginning of period Outstanding end of period Number of Options Outstanding Outstanding beginning of period Outstanding end of period Weighted Average Exercise Price of Outstanding Options (in Dollars per share) Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted Expired/Cancelled Expired/Cancelled Exercised Exercised Exercisable Number of Exercisable Options Exercisable Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Abstract] Exercise Price Range [Axis] Options at $0.08 [Member] Exercise Price of Options (in Dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price Weighted Average Remaining Contractual Life of Outstanding Options Weighted Average Remaining Contractual Life of Exercisable Options Options at $0.10 [Member] Options at $0.17 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] ASSETS CURRENT ASSETS PROPERTY AND EQUIPMENT OTHER ASSETS LIABILITIES AND STOCKHOLDER’S EQUITY CURRENT LIABILITIES LONG-TERM LIABILITIES Long-term debt Long-term Debt, Excluding Current Maturities STOCKHOLDERS’ EQUITY NET SALES COST OF REVENUES EXPENSES OTHER (EXPENSE)/INCOME CASH FLOWS FROM OPERATING ACTIVITIES Adjustments to reconcile net loss to net cash used by operating activities: Changes in operating assets and liabilities: Accounts payable and accrued expenses CASH FLOWS FROM INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES NON-CASH FINANCING ACTIVITIES SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Significant Accounting Policies [Text Block] Inventory Disclosure [Text Block] Schedule of Inventory [Table Text Block] Raw Materials Finished Goods Debt Disclosure [Text Block] Schedule of Maturities of Long-term Debt [Table Text Block] Total Less than 1 year 1 to 3 years 3 to 5 years After 5 years Debt and Capital Leases Disclosures [Text Block] Schedule of Capital Leased Assets [Table Text Block] 2017 2018 2019 2020 Shareholders' Equity and Share-based Payments [Text Block] Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Outstanding end of period Exercisable Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Substantial Doubt about Going Concern [Text Block] Inventory reserve Notes Payable, Other Payables [Member] Award Date [Axis] Options Granted December 1, 2015 [Member] Related Party [Axis] Chief Executive Officer [Member] Options Granted January 19, 2016 [Member] Board member [Member] Audit Committee Chair [Member] Options Granted October 2015 [Member] Board Members and Audito Committe Chair [Member] Chief Financial Officer [Member] Range [Axis] Minimum [Member] Maximum [Member] Convertible Debt [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Prior Period Reclassification Adjustment EX-101.PRE 10 amty-20160930_pre.xml XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE EX-101.SCH 11 amty-20160930.xsd XBRL TAXONOMY EXTENSION - SCHEMA 001 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Statements of Operations (Unaudited) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:definitionLink link:calculationLink 005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - NOTE 3 - INVENTORY link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - NOTE 4 - DEBT link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - NOTE 5 - CAPITAL LEASE link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - NOTE 7 - LIQUIDITY link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - NOTE 3 - INVENTORY (Tables) link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - NOTE 4 - DEBT (Tables) link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - NOTE 5 - CAPITAL LEASE (Tables) link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - NOTE 3 - INVENTORY (Details) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - NOTE 3 - INVENTORY (Details) - Schedule of Inventory link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - NOTE 4 - DEBT (Details) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - NOTE 7 - LIQUIDITY (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink XML 12 amty-20160930_htm.xml IDEA: XBRL DOCUMENT 0000945828 2016-09-30 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-06-30 0000945828 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-01 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-09-30 0000945828 2015-07-31 0000945828 amty:OptionsGrantedDecember1_2015Member us-gaap:ChiefExecutiveOfficerMember 2015-12-01 2015-12-01 0000945828 amty:OptionsGrantedDecember1_2015Member us-gaap:ChiefExecutiveOfficerMember 2015-12-01 0000945828 2016-06-30 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMemberMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:AuditCommitteeChairMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedOctober2015Member amty:BoardMembersAndAuditoCommitteChairMember 2015-10-01 2015-10-31 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMembersAndAuditoCommitteChairMember 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member amty:BoardMembersAndAuditoCommitteChairMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:MinimumMember us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:MaximumMember us-gaap:ChiefFinancialOfficerMember 2016-01-19 2016-01-19 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2016-07-01 2016-09-30 0000945828 2016-07-01 2016-09-30 0000945828 us-gaap:ConvertibleDebtMember 2013-09-30 0000945828 us-gaap:ConvertibleDebtMember 2013-09-01 2013-09-30 0000945828 2015-07-01 2016-06-30 0000945828 amty:OptionsAt0.08Member 2016-09-30 0000945828 amty:OptionsAt0.08Member 2016-07-01 2016-09-30 0000945828 amty:OptionsAt0.10Member 2016-09-30 0000945828 amty:OptionsAt0.10Member 2016-07-01 2016-09-30 0000945828 amty:OptionsAt017Member 2016-09-30 0000945828 amty:OptionsAt017Member 2016-07-01 2016-09-30 0000945828 2015-07-01 2015-09-30 0000945828 2015-06-30 0000945828 2015-09-30 0000945828 2016-11-04 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-07-01 2016-09-30 0000945828 us-gaap:NotesPayableOtherPayablesMember 2016-09-30 iso4217:USD iso4217:USD shares shares pure false 10-Q 2016-09-30 42325287

201470

267302

372492

293358

625072

614895

74475

103803

1273509

1279358

196223

153543

577549

2988844

2960246

74921

39593

10198

305924

3869113

3849937

313941

232444

168555

175379

185260

180050

11000

364815

366429

1952265

1878231

439600

348499

18656

20518

6578

6249

464834

375266

138139

100142

6621

8394

144760

108536

609594

483802

5000000

0.001

2000000

2000

75000000

0.001

42325287

42175287

42325

42175

62591976

62579558

4500

-61293630

-61233804

1342671

1394429

1952265

1878231

836153

1013933

555452

766776

280701

247157

52859

53605

67230

97664

192306

224840

312395

376109

-31694

-128952

3185

599

-3132

-526

-34826

-129478

25000

-59826

-154478

0.00

42302461

41631157

-34826

-129478

26000

39508

-289

8068

10768

79134

185831

28665

36091

15387

5094

66101

-2627

-57843

-309134

5048

-5048

1444

778

1497

560

25000

-2941

-26338

-65832

-335472

267302

455717

201470

120245

3185

599

19337

81224

95625

25000

4500

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. We believe the disclosures and information presented are adequate to make the information not misleading. These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K. Operating results for the quarter ended September 30, 2016 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2016.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K, except as noted below.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Reclassifications</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify">Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of ???store??? inventory as part of other current assets at September 30, 2015.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Basic and Fully Diluted Net Loss Per Share</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation. We excluded 3,800,000 and 3,370,000 common stock equivalents for the quarters ended September 30, 2016 and 2015, respectively, because they are anti-dilutive.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Recent Accounting Pronouncements</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Recently Adopted and Recently Issued Accounting Guidance</span></div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Issued</span></div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; ">In August, the FASB issued ASU No. 2016-15, ???<span style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)</span>??? ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Reclassifications</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify">Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of ???store??? inventory as part of other current assets at September 30, 2015.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Basic and Fully Diluted Net Loss Per Share</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation. We excluded 3,800,000 and 3,370,000 common stock equivalents for the quarters ended September 30, 2016 and 2015, respectively, because they are anti-dilutive.</div>

3800000

3370000

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">Recent Accounting Pronouncements</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Recently Adopted and Recently Issued Accounting Guidance</span></div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Issued</span></div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: justify; ">In August, the FASB issued ASU No. 2016-15, ???<span style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)</span>??? ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 3 - INVENTORY</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market. The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.</div><table border="0" cellpadding="0" cellspacing="0" id="zb1b42931bb1e48adb394f0a9e194b39d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 75%; text-align: center;"> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 43%" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">September 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">June 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 43%" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(Unaudited)</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 43%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Raw Materials</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">228,232</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">257,260</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 43%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Finished Goods</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">628,957</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">663,666</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 43%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory reserve</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 13%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">(46,856</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 13%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(125,981</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 43%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory ??? net (current and long term)</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 13%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">810,333</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 13%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">794,945</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In fiscal years 2017 and 2016, the Company critically reviewed all slow moving inventory to determine if defective or obsolete. If not defective or obsolete we presented these items as non-current inventory, although all inventory is ready and available for sale at any moment. </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">For those items that are spare maintenance materials or parts kept on hand as backup components of major production lines, or ???store inventories???, the Company capitalizes the amount if above our capitalization policy for property and equipment. In the past we have included these items as part of our raw materials inventory. As of September 30, 2015 these items, amounting to $10,815, have been reclassified into other current assets. </div>

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market. The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.<table border="0" cellpadding="0" cellspacing="0" id="zb1b42931bb1e48adb394f0a9e194b39d" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 75%; text-align: center;"> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 43%" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">September 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">June 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 43%" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">(Unaudited)</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 43%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Raw Materials</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">228,232</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">257,260</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 43%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Finished Goods</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">628,957</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 13%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">663,666</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 43%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory reserve</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 13%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">(46,856</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 13%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(125,981</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">)</div> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 43%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Inventory ??? net (current and long term)</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 13%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">810,333</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 13%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">794,945</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

228232

257260

628957

663666

46856

125981

810333

794945

10815

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 4 ??? DEBT</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">A former board member, Silas O. Kines, who passed away on January 11, 2012, was also the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc. In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales. In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long term liability recorded on the transaction. As of September 30, 2016, $2,000 and $63,425 (June 30, 2016, $11,752 and $53,840) were recorded for the current and long-term portion, respectively, of the related liability.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In June 2016, the Company executed a term note with U.S. Bank to finance critical manufacturing equipment and operating enhancements. Manufacturing equipment of approximately $29,000 was place in service in July 2016. The remaining operating enhancements are expected to be in service at the end of the second quarter of fiscal 2017. Total amount financed was $55,068, at 5.59% interest, with payments of $1,059 due for 60 months starting July 2016.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In July 2016, the Company executed a term note with U.S. Bank to finance critical plant facility equipment which was placed into service in July 2017. The total amount financed was $37,666 at 5.59% interest, with payments of $720 due for 60 months starting October 2016.</div><table cellpadding="0" cellspacing="0" id="zbdd366e48f6741ecac99863e879f7ea7" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td colspan="19" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Payments due by period</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Total</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Less than</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">1 year</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">1 to 3 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">3 to 5 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">After</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">5 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td colspan="19" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Bank debt (both US Bank facilities above)</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">91,384</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">16,656</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">59,726</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">15,001</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 30%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt">Total cash obligations</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">91,384</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">16,656</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">59,726</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">15,001</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

0.05

96000

2000

63425

11752

53840

29000

55068

0.0559

1059

P60M0D

37666

0.0559

720

P60M0D

<table cellpadding="0" cellspacing="0" id="zbdd366e48f6741ecac99863e879f7ea7" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td colspan="19" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Payments due by period</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Total</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Less than</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">1 year</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">1 to 3 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">3 to 5 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">After</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">5 years</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td colspan="19" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Bank debt (both US Bank facilities above)</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">91,384</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">16,656</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">59,726</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">15,001</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 30%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 30%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt">Total cash obligations</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">91,384</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">16,656</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">59,726</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">15,001</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

91384

16656

59726

15001

91384

16656

59726

15001

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 5 - CAPITAL LEASE</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In July 2015 the Company entered into a capital lease for research and development equipment for $19,337 (which has accumulated depreciation of $4,673).</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of September 30, 2016:</div><table border="0" cellpadding="0" cellspacing="0" id="zc2e74d180ad643d3b55f94c17b8ad9d4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 50%; text-align: center;"> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2017</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">6,523</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2018</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">8,697</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2019</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">725</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2020</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2021</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Total minimum lease payments</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">15,945</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Less: executory costs</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Net minimum lease payments</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">15,945</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Less: amount representing interest</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2,761</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Present value of net minimum payments</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">13,184</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

19337

4673

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of September 30, 2016:<table border="0" cellpadding="0" cellspacing="0" id="zc2e74d180ad643d3b55f94c17b8ad9d4" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 50%; text-align: center;"> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2017</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">6,523</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2018</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">8,697</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2019</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">725</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2020</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">2021</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Total minimum lease payments</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">15,945</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Less: executory costs</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Net minimum lease payments</div> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">15,945</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 36%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Less: amount representing interest</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">2,761</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 36%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Present value of net minimum payments</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">$</div> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">13,184</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

6523

8697

725

15945

2761

13184

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 6 - STOCK OPTIONS AND WARRANTS</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><span style="text-decoration:underline">Prior Issuances of options</span></div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On December 1, 2015, 480,000 options were granted to the Company???s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer. The options have a strike price of $0.10, vest December 1, 2016 and expire December 1, 2020. </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On January 19, 2016, the Board granted all non-executive Board members 100,000 options, with the audit committee chair receiving an additional 50,000 options, for Board services rendered for the Board term ending December 2016. The options have a strike price of $0.10, vest at the end of the Board term in December 2016 and expire December 2019. </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">On January 19, 2016, 50,000 options were granted to the Company???s Chief Financial Officer as part of renewal of her employment agreement. The options have a strike price of $0.10, vest ratably January 21, 2016 to December 1, 2016 and expire December 1, 2019. In addition to the option renewal $550 a month in health insurance reimbursement was included in the renewal. All other terms remain the same. </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">Year to date expense related to these options is $8,068 as of September 30, 2016.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">A summary of the status of our outstanding stock options as of September 30, 2016 and June 30, 2016 and changes during the periods then ended is presented below:</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">The following table summarizes the range of outstanding and exercisable options as of September 30, 2016:</div><table cellpadding="0" cellspacing="0" id="z95e90333c4c147d690f9fda6dace8bb3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="10" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">September 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="10" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weight Average</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Intrinsic</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weight Average</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Intrinsic</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Shares</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercise Price</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Value</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Shares</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercise Price</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Value</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Outstanding beginning of period</div> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,800,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2,270,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.14</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Granted</div> </td> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1,530,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Expired/Cancelled</div> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Exercised</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Outstanding end of period</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,800,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,800,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 16%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Exercisable</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,195,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,070 ,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><table cellpadding="0" cellspacing="0" id="z6c4c262136e1494c852dd4b895990165" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="10" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Outstanding</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="6" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercisable</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Range of</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercise Prices</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Number Outstanding</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">at</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">September 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Average</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Remaining</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Contractual Life</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Average</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercise Price</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Number</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercisable at</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">September 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Average Remaining</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Contractual Life</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.08</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">150,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.17</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.08</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">150,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.17</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2,200,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.59</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1,595,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.59</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1,450,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1,450,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,800,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,195,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">General Warrant Information</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010. This note was paid off as of June 30, 2015. In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees. The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share. As of September 30, 2016 the warrants expired.</div>

480000

0.10 2016-12-01

2020-12-01

100000

50000

December 2016 0.10 December 2016 December 2019

50000

0.10 2016-01-21 2016-12-01

2019-12-01

550

8068

The following table summarizes the range of outstanding and exercisable options as of September 30, 2016:<table cellpadding="0" cellspacing="0" id="z95e90333c4c147d690f9fda6dace8bb3" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="10" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">September 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="10" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">June 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weight Average</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Intrinsic</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weight Average</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Intrinsic</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"> </div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Shares</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercise Price</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Value</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Shares</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercise Price</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Value</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Outstanding beginning of period</div> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,800,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2,270,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.14</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Granted</div> </td> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1,530,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Expired/Cancelled</div> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Exercised</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.00</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td colspan="3" style="VERTICAL-ALIGN: bottom; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 16%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Outstanding end of period</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,800,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,800,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 16%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Exercisable</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,195,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,070 ,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.13</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">-</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

3800000

0.13

2270000

0.14

0.00

1530000

0.10

0.00

3800000

0.13

3800000

0.13

3195000

0.13

0.08

150000

P5Y2M1D

0.08

150000

P5Y2M1D

0.10

2200000

P2Y7M2D

0.10

1595000

P2Y7M2D

0.17

1450000

P4Y2M1D

0.17

1450000

P4Y2M1D

3800000

3195000

100000

500000

6500

0.13

0.25

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">NOTE 7 - LIQUIDITY</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Our principal sources of liquidity consist of cash and payments received from our customers. We do not have any significant revolving credit arrangements. Historically, our expenses have exceeded our sales, resulting in operating losses. From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments. At the end of 2016 and early 2017, we were able to obtain term bank debt financing to finance critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017. Management continues to evaluate financing options but is choosing to delay financing at terms that will subject the Company to high costs of debt and are reluctant to raise money through stock sales at what we believe are highly dilutive share prices. Additionally, management has notified our preferred shareholder that we will be suspending future payments of their preferred cash dividend payments, so the Company can increase its working capital levels.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">We have been working during the past year to improve our liquidity and access to capital resources. In order to execute the strategic business plan discussed during our shareholder meeting in December 2015, we require more capital resources. We will continue to pursue potential opportunities to secure short-term loans, long-term bank financing, revolving lines of credit with banking institutions and equity based transactions with interested financial firms and strategic industry partners in our effort to improve the Company???s financial position and enhance shareholder value.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments. The Company currently does not have an existing revolving credit facility. In June and July 2016, in two separate bank promissory notes, we financed critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017. Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to that required to maintain current manufacturing capability or support business initiatives identified in our strategic sales plan. We continue to work to reduce our overall costs wherever possible.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit. Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices. This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Management continues to execute its strategic plan focusing on ???Profitability as a Mindset???. The Company???s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales. Improvement in results has continued and the Company has been successful in reducing its required breakeven sales level. We believe our program to establish ???Profitability as a Mindset??? is a success and we are committed to continuing these efforts. </div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations. In connection with the preparation of our financial statements for the period ended September 30, 2016, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period. However, to expand manufacturing and sales operations beyond the current level, additional capital may be required.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">The Company has, on occasion, instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be selectively utilized in the upcoming quarters to monetize inventory and improve our cash flow.</div><div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">As of November 4, 2016 the Company has approximately 7,488,713 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.</div>

7488713

The following table summarizes the range of outstanding and exercisable options as of September 30, 2016:<table cellpadding="0" cellspacing="0" id="z6c4c262136e1494c852dd4b895990165" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%"> <tr> <td colspan="2" style="VERTICAL-ALIGN: bottom" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="10" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Outstanding</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="6" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercisable</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Range of</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercise Prices</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Number Outstanding</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">at</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">September 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Average</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Remaining</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Contractual Life</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Average</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercise Price</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Number</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Exercisable at</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">September 30, 2016</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px" valign="bottom"> </td> <td colspan="2" style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Weighted</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Average Remaining</div> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Contractual Life</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.08</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">150,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.17</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.08</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">150,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">5.17</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2,200,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.59</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.10</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1,595,000</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">2.59</div> </td> <td style="VERTICAL-ALIGN: bottom; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1,450,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">$</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">0.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">1,450,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: right; WIDTH: 11%; BACKGROUND-COLOR: #cceeff" valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">4.17</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 2px; TEXT-ALIGN: left; WIDTH: 1%; BACKGROUND-COLOR: #cceeff; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,800,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 4px double; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> <div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">3,195,000</div> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: right; WIDTH: 11%; " valign="bottom"> </td> <td style="VERTICAL-ALIGN: bottom; PADDING-BOTTOM: 4px; TEXT-ALIGN: left; WIDTH: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

Amerityre Corp --06-30 0000945828 Yes No Smaller Reporting Company No 2017 Q1 P3Y

3070000

XML 13 R1.htm IDEA: XBRL DOCUMENT

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Sep. 30, 2016	Nov. 04, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	Amerityre Corp
Document Type	10-Q
Current Fiscal Year End Date	--06-30
Entity Common Stock, Shares Outstanding		42,325,287
Amendment Flag	false
Entity Central Index Key	0000945828
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1

XML 14 R2.htm IDEA: XBRL DOCUMENT

Balance Sheets - USD ($)	Sep. 30, 2016	Jun. 30, 2016
CURRENT ASSETS
Cash	$ 201,470	$ 267,302
Accounts receivable - net	372,492	293,358
Inventory - net	625,072	614,895
Prepaid and other current assets	74,475	103,803
Total Current Assets	1,273,509	1,279,358
PROPERTY AND EQUIPMENT
Leasehold improvements	196,223	153,543
Molds and models	577,549	577,549
Equipment	2,988,844	2,960,246
Furniture and fixtures	74,921	74,921
Construction in progress	39,593	10,198
Software	305,924	305,924
Less - accumulated depreciation	(3,869,113)	(3,849,937)
Total Property and Equipment	313,941	232,444
OTHER ASSETS
Patents and trademarks - net	168,555	175,379
Non-current inventory	185,260	180,050
Deposits	11,000	11,000
Total Other Assets	364,815	366,429
TOTAL ASSETS	1,952,265	1,878,231
CURRENT LIABILITIES
Accounts payable and accrued expenses	439,600	348,499
Current portion of long-term debt	18,656	20,518
Current portion of lease liability	6,578	6,249
Total Current Liabilities	464,834	375,266
LONG-TERM LIABILITIES
Long-term debt	138,139	100,142
Long-term lease liability	6,621	8,394
Total Long Term Liability	144,760	108,536
Total Liabilities	609,594	483,802
STOCKHOLDERS’ EQUITY
Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively	2,000	2,000
Common Stock: 75,000,000 shares authorized of $0.001 par value, 42,325,287 and 42,175,287 shares issued and outstanding, respectively	42,325	42,175
Additional paid-in capital	62,591,976	62,579,558
Stock payable	0	4,500
Accumulated deficit	(61,293,630)	(61,233,804)
Total Stockholders’ Equity	1,342,671	1,394,429
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 1,952,265	$ 1,878,231

XML 15 R3.htm IDEA: XBRL DOCUMENT

Balance Sheets (Parentheticals) - $ / shares	Sep. 30, 2016	Jun. 30, 2016
Preferred stock par value (in Dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	2,000,000	2,000,000
Preferred stock, shares outstanding	2,000,000	2,000,000
Common stock par value (in Dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	42,325,287	42,175,287
Common stock, shares outstanding	42,325,287	42,175,287

XML 16 R4.htm IDEA: XBRL DOCUMENT

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
Statements of Operations (Unaudited) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
NET SALES	$ 836,153	$ 1,013,933
COST OF REVENUES	555,452	766,776
GROSS PROFIT	280,701	247,157
EXPENSES
Research and development	52,859	53,605
Sales and marketing	67,230	97,664
General and administrative	192,306	224,840
Total Expenses	312,395	376,109
LOSS FROM OPERATIONS	(31,694)	(128,952)
OTHER (EXPENSE)/INCOME
Interest income	53	73
Interest expense	(3,185)	(599)
Total Other (Expense)/Income	(3,132)	(526)
NET LOSS	(34,826)	(129,478)
Preferred Stock Dividend	(25,000)	(25,000)
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS	$ (59,826)	$ (154,478)
BASIC AND DILUTED LOSS PER SHARE (in Dollars per share)	$ 0.00	$ 0.00
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in Shares)	42,302,461	41,631,157

XML 17 R5.htm IDEA: XBRL DOCUMENT

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (34,826)	$ (129,478)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization expense	26,000	39,508
Change in allowance for bad debt expense (recovery)		(289)
Stock based compensation	8,068	10,768
Changes in operating assets and liabilities:
Accounts receivable	(79,134)	(185,831)
Prepaid and other current assets	(28,665)	(36,091)
Inventory and any change in inventory reserve	(15,387)	(5,094)
Accounts payable and accrued expenses	66,101	(2,627)
Net Cash Used by Operating Activities	(57,843)	(309,134)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(5,048)	0
Net Cash Used by Investing Activities	(5,048)	0
CASH FLOWS FROM FINANCING ACTIVITIES
Payment on lease liability	(1,444)	(778)
Payments on notes payable	(1,497)	(560)
Preferred stock dividends	0	(25,000)
Net Cash Used by Financing Activities	(2,941)	(26,338)
NET DECREASE IN CASH	(65,832)	(335,472)
CASH AT BEGINNING OF PERIOD	267,302	455,717
CASH AT END OF PERIOD	201,470	120,245
NON-CASH FINANCING ACTIVITIES
Interest paid	3,185	599
Income taxes paid	0	0
SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES
Capitalized lease	0	19,337
Write off of previous reserved forklift tires	81,224	0
Purchase of fixed assets through debt	95,625	0
Accrued preferred stock dividends	25,000	0
Issuance of stock for stock payable	$ 4,500	$ 0

XML 18 R6.htm IDEA: XBRL DOCUMENT

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION	3 Months Ended
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION	Sep. 30, 2016
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. We believe the disclosures and information presented are adequate to make the information not misleading. These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K. Operating results for the quarter ended September 30, 2016 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2016.

XML 19 R7.htm IDEA: XBRL DOCUMENT

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2016
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2016 Annual Report on Form 10-K, except as noted below. Reclassifications Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of “store” inventory as part of other current assets at September 30, 2015. Basic and Fully Diluted Net Loss Per Share Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period. Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation. We excluded 3,800,000 and 3,370,000 common stock equivalents for the quarters ended September 30, 2016 and 2015, respectively, because they are anti-dilutive. Recent Accounting Pronouncements Recently Adopted and Recently Issued Accounting Guidance Issued In August, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)” ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.

XML 20 R8.htm IDEA: XBRL DOCUMENT

NOTE 3 - INVENTORY

3 Months Ended

Sep. 30, 2016

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

NOTE 3 - INVENTORY

	September 30, 2016			June 30, 2016
	(Unaudited)
Raw Materials	$	228,232		$	257,260
Finished Goods		628,957			663,666
Inventory reserve		(46,856	)		(125,981	)
Inventory – net (current and long term)	$	810,333		$	794,945

Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.

XML 21 R9.htm IDEA: XBRL DOCUMENT

NOTE 4 - DEBT

3 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

NOTE 4 – DEBT

	Payments due by period
	Total			Less than 1 year		1 to 3 years		3 to 5 years		After 5 years

Bank debt (both US Bank facilities above)		$	91,384	$	16,656	$	59,726	$	15,001	$	-

Total cash obligations		$	91,384	$	16,656	$	59,726	$	15,001	$	-

XML 22 R10.htm IDEA: XBRL DOCUMENT

NOTE 5 - CAPITAL LEASE

3 Months Ended

Sep. 30, 2016

Disclosure Text Block Supplement [Abstract]

Debt and Capital Leases Disclosures [Text Block]

NOTE 5 - CAPITAL LEASE

In July 2015 the Company entered into a capital lease for research and development equipment for $19,337 (which has accumulated depreciation of $4,673).

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of September 30, 2016:

2017	$	6,523
2018		8,697
2019		725
2020		-
2021		-
Total minimum lease payments		15,945
Less: executory costs		-
Net minimum lease payments		15,945
Less: amount representing interest		2,761
Present value of net minimum payments	$	13,184

XML 23 R11.htm IDEA: XBRL DOCUMENT

NOTE 6 - STOCK OPTIONS AND WARRANTS

3 Months Ended

Sep. 30, 2016

Disclosure Text Block Supplement [Abstract]

Shareholders' Equity and Share-based Payments [Text Block]

NOTE 6 - STOCK OPTIONS AND WARRANTS

Prior Issuances of options

Year to date expense related to these options is $8,068 as of September 30, 2016.

A summary of the status of our outstanding stock options as of September 30, 2016 and June 30, 2016 and changes during the periods then ended is presented below:

The following table summarizes the range of outstanding and exercisable options as of September 30, 2016:

	September 30, 2016							June 30, 2016
			Weight Average		Intrinsic					Weight Average		Intrinsic
	Shares		Exercise Price		Value			Shares		Exercise Price		Value
Outstanding beginning of period		3,800,000	$	0.13					2,270,000	$	0.14
Granted		-	$	0.00					1,530,000	$	0.10
Expired/Cancelled		-	$	0.00					-	$	0.00
Exercised		-	$	0.00					-	$	0.00
Outstanding end of period		3,800,000	$	0.13		$	-		3,800,000	$	0.13		$	-
Exercisable		3,195,000	$	0.13		$	-		3,070 ,000	$	0.13		$	-

		Outstanding						Exercisable
Range of Exercise Prices		Number Outstanding at September 30, 2016		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable at September 30, 2016		Weighted Average Remaining Contractual Life
$	0.08		150,000		5.17	$	0.08		150,000		5.17
$	0.10		2,200,000		2.59	$	0.10		1,595,000		2.59
$	0.17		1,450,000		4.17	$	0.17		1,450,000		4.17
			3,800,000						3,195,000

General Warrant Information

XML 24 R12.htm IDEA: XBRL DOCUMENT

NOTE 7 - LIQUIDITY	3 Months Ended
NOTE 7 - LIQUIDITY	Sep. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Substantial Doubt about Going Concern [Text Block]	NOTE 7 - LIQUIDITY Our principal sources of liquidity consist of cash and payments received from our customers. We do not have any significant revolving credit arrangements. Historically, our expenses have exceeded our sales, resulting in operating losses. From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments. At the end of 2016 and early 2017, we were able to obtain term bank debt financing to finance critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017. Management continues to evaluate financing options but is choosing to delay financing at terms that will subject the Company to high costs of debt and are reluctant to raise money through stock sales at what we believe are highly dilutive share prices. Additionally, management has notified our preferred shareholder that we will be suspending future payments of their preferred cash dividend payments, so the Company can increase its working capital levels. We have been working during the past year to improve our liquidity and access to capital resources. In order to execute the strategic business plan discussed during our shareholder meeting in December 2015, we require more capital resources. We will continue to pursue potential opportunities to secure short-term loans, long-term bank financing, revolving lines of credit with banking institutions and equity based transactions with interested financial firms and strategic industry partners in our effort to improve the Company’s financial position and enhance shareholder value. Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments. The Company currently does not have an existing revolving credit facility. In June and July 2016, in two separate bank promissory notes, we financed critical manufacturing and facility equipment and operating enhancements which will be placed in service in fiscal year 2017. Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted. We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to that required to maintain current manufacturing capability or support business initiatives identified in our strategic sales plan. We continue to work to reduce our overall costs wherever possible. To help address our cash resources which at times may be limited, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit. Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices. This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed. Management continues to execute its strategic plan focusing on “Profitability as a Mindset”. The Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales. Improvement in results has continued and the Company has been successful in reducing its required breakeven sales level. We believe our program to establish “Profitability as a Mindset” is a success and we are committed to continuing these efforts. In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations. In connection with the preparation of our financial statements for the period ended September 30, 2016, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period. However, to expand manufacturing and sales operations beyond the current level, additional capital may be required. The Company has, on occasion, instituted initiatives to incentivize sales of slower moving inventory through promotional pricing. These programs will continue to be selectively utilized in the upcoming quarters to monetize inventory and improve our cash flow. As of November 4, 2016 the Company has approximately 7,488,713 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.

XML 25 R13.htm IDEA: XBRL DOCUMENT

Accounting Policies, by Policy (Policies)	3 Months Ended
Accounting Policies, by Policy (Policies)	Sep. 30, 2016
Accounting Policies [Abstract]
Reclassification, Policy [Policy Text Block]	Reclassifications Certain reclassifications, which have no effect on net loss, have been made in the prior period financial statements to conform to the current presentation, specifically the separation of “store” inventory as part of other current assets at September 30, 2015.
Earnings Per Share, Policy [Policy Text Block]	Basic and Fully Diluted Net Loss Per Share Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period. Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation. We excluded 3,800,000 and 3,370,000 common stock equivalents for the quarters ended September 30, 2016 and 2015, respectively, because they are anti-dilutive.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements Recently Adopted and Recently Issued Accounting Guidance Issued In August, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (consensus of Emerging Issues Task Force)” ASU 2016-15 amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. For all other public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period.

XML 26 R14.htm IDEA: XBRL DOCUMENT

NOTE 3 - INVENTORY (Tables)

3 Months Ended

Sep. 30, 2016

Inventory Disclosure [Abstract]

Schedule of Inventory [Table Text Block]

	September 30, 2016			June 30, 2016
	(Unaudited)
Raw Materials	$	228,232		$	257,260
Finished Goods		628,957			663,666
Inventory reserve		(46,856	)		(125,981	)
Inventory – net (current and long term)	$	810,333		$	794,945

XML 27 R15.htm IDEA: XBRL DOCUMENT

NOTE 4 - DEBT (Tables)

3 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

Schedule of Maturities of Long-term Debt [Table Text Block]

	Payments due by period
	Total			Less than 1 year		1 to 3 years		3 to 5 years		After 5 years

Bank debt (both US Bank facilities above)		$	91,384	$	16,656	$	59,726	$	15,001	$	-

Total cash obligations		$	91,384	$	16,656	$	59,726	$	15,001	$	-

XML 28 R16.htm IDEA: XBRL DOCUMENT

NOTE 5 - CAPITAL LEASE (Tables)

3 Months Ended

Sep. 30, 2016

Disclosure Text Block Supplement [Abstract]

Schedule of Capital Leased Assets [Table Text Block]

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of September 30, 2016:

2017	$	6,523
2018		8,697
2019		725
2020		-
2021		-
Total minimum lease payments		15,945
Less: executory costs		-
Net minimum lease payments		15,945
Less: amount representing interest		2,761
Present value of net minimum payments	$	13,184

XML 29 R17.htm IDEA: XBRL DOCUMENT

NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables)

3 Months Ended

Sep. 30, 2016

Disclosure Text Block Supplement [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following table summarizes the range of outstanding and exercisable options as of September 30, 2016:

	September 30, 2016							June 30, 2016
			Weight Average		Intrinsic					Weight Average		Intrinsic
	Shares		Exercise Price		Value			Shares		Exercise Price		Value
Outstanding beginning of period		3,800,000	$	0.13					2,270,000	$	0.14
Granted		-	$	0.00					1,530,000	$	0.10
Expired/Cancelled		-	$	0.00					-	$	0.00
Exercised		-	$	0.00					-	$	0.00
Outstanding end of period		3,800,000	$	0.13		$	-		3,800,000	$	0.13		$	-
Exercisable		3,195,000	$	0.13		$	-		3,070 ,000	$	0.13		$	-

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

The following table summarizes the range of outstanding and exercisable options as of September 30, 2016:

		Outstanding						Exercisable
Range of Exercise Prices		Number Outstanding at September 30, 2016		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Number Exercisable at September 30, 2016		Weighted Average Remaining Contractual Life
$	0.08		150,000		5.17	$	0.08		150,000		5.17
$	0.10		2,200,000		2.59	$	0.10		1,595,000		2.59
$	0.17		1,450,000		4.17	$	0.17		1,450,000		4.17
			3,800,000						3,195,000

XML 30 R18.htm IDEA: XBRL DOCUMENT

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - shares	3 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Accounting Policies [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	3,800,000	3,370,000

XML 31 R19.htm IDEA: XBRL DOCUMENT

NOTE 3 - INVENTORY (Details)	3 Months Ended
NOTE 3 - INVENTORY (Details)	Sep. 30, 2016 USD ($)
Inventory Disclosure [Abstract]
Prior Period Reclassification Adjustment	$ 10,815

XML 32 R20.htm IDEA: XBRL DOCUMENT

NOTE 3 - INVENTORY (Details) - Schedule of Inventory - USD ($)	Sep. 30, 2016	Jun. 30, 2016
Schedule of Inventory [Abstract]
Raw Materials	$ 228,232	$ 257,260
Finished Goods	628,957	663,666
Inventory reserve	(46,856)	(125,981)
Inventory – net (current and long term)	$ 810,333	$ 794,945

XML 33 R21.htm IDEA: XBRL DOCUMENT

NOTE 4 - DEBT (Details) - USD ($)	1 Months Ended		3 Months Ended
NOTE 4 - DEBT (Details) - USD ($)	Jul. 31, 2016	Jun. 30, 2016	Sep. 30, 2016
NOTE 4 - DEBT (Details) [Line Items]
Long-term Debt, Current Maturities		$ 20,518	$ 18,656
Long-term Debt, Excluding Current Maturities		100,142	$ 138,139
Property, Plant and Equipment, Transfers and Changes	$ 29,000
Notes Payable, Other Payables [Member]
NOTE 4 - DEBT (Details) [Line Items]
Sales Commission, Percentage			5.00%
Debt Instrument, Face Amount			$ 96,000
Long-term Debt, Current Maturities		11,752	2,000
Long-term Debt, Excluding Current Maturities		53,840	$ 63,425
Notes Payable to Banks [Member]
NOTE 4 - DEBT (Details) [Line Items]
Debt Instrument, Face Amount	$ 37,666	$ 55,068
Debt Instrument, Interest Rate, Stated Percentage	5.59%	5.59%
Debt Instrument, Periodic Payment	$ 720	$ 1,059
Debt Instrument, Term	60 months	60 months

XML 34 R22.htm IDEA: XBRL DOCUMENT

NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt	Sep. 30, 2016 USD ($)
NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt [Line Items]
Total	$ 91,384
Less than 1 year	16,656
1 to 3 years	59,726
3 to 5 years	15,001
After 5 years	0
Notes Payable to Banks [Member]
NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt [Line Items]
Total	91,384
Less than 1 year	16,656
1 to 3 years	59,726
3 to 5 years	15,001
After 5 years	$ 0

XML 35 R23.htm IDEA: XBRL DOCUMENT

NOTE 5 - CAPITAL LEASE (Details) - USD ($)	Sep. 30, 2016	Jul. 31, 2015
Disclosure Text Block Supplement [Abstract]
Capital Leases, Future Minimum Payments Due	$ 15,945	$ 19,337
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation	$ 4,673

XML 36 R24.htm IDEA: XBRL DOCUMENT

NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets - USD ($)	Sep. 30, 2016	Jul. 31, 2015
Schedule of Capital Leased Assets [Abstract]
2017	$ 6,523
2018	8,697
2019	725
2020	0
2021	0
Total minimum lease payments	15,945	$ 19,337
Less: executory costs	0
Net minimum lease payments	15,945
Less: amount representing interest	2,761
Present value of net minimum payments	$ 13,184

XML 37 R25.htm IDEA: XBRL DOCUMENT

NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - USD ($)			1 Months Ended		3 Months Ended		12 Months Ended
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - USD ($)	Jan. 19, 2016	Dec. 01, 2015	Oct. 31, 2015	Sep. 30, 2013	Sep. 30, 2016	Sep. 30, 2015	Jun. 30, 2016
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					0		1,530,000
Interest Paid					$ 3,185	$ 599
Convertible Debt [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Convertible Notes Payable, Current				$ 100,000
Class of Warrant or Rights, Granted				500,000
Interest Paid				$ 6,500
Warrants, Term of Warrants				3 years
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.13
Share Price				$ 0.25
Chief Executive Officer [Member] \| Options Granted December 1, 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		480,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price		$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date		Dec. 01, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date		Dec. 01, 2020
Board member [Member] \| Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	100,000
Audit Committee Chair [Member] \| Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	50,000
Board Members and Audito Committe Chair [Member] \| Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price	$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date	December 2016
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	December 2019
Board Members and Audito Committe Chair [Member] \| Options Granted October 2015 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date			December 2016
Chief Financial Officer [Member] \| Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	50,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price	$ 0.10
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date	Dec. 01, 2019
Monthly Health Insurance Reimbursement	$ 550
Allocated Share-based Compensation Expense					$ 8,068
Minimum [Member] \| Chief Financial Officer [Member] \| Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date	Jan. 21, 2016
Maximum [Member] \| Chief Financial Officer [Member] \| Options Granted January 19, 2016 [Member]
NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date	Dec. 01, 2016

XML 38 R26.htm IDEA: XBRL DOCUMENT

NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity - USD ($)	3 Months Ended	12 Months Ended
	Sep. 30, 2016	Jun. 30, 2016
Schedule of Share-based Compensation, Stock Options, Activity [Abstract]
Outstanding beginning of period	3,800,000	2,270,000
Outstanding beginning of period	$ 0.13	$ 0.14
Granted	0	1,530,000
Granted	$ 0.00	$ 0.10
Expired/Cancelled	0	0
Expired/Cancelled	$ (0.00)	$ (0.00)
Exercised	0	0
Exercised	$ 0.00	$ 0.00
Outstanding end of period	3,800,000	3,800,000
Outstanding end of period	$ 0.13	$ 0.13
Outstanding end of period	$ 0	$ 0
Exercisable	3,195,000	3,070,000
Exercisable	$ 0.13	$ 0.13
Exercisable	$ 0	$ 0

XML 39 R27.htm IDEA: XBRL DOCUMENT

NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range - $ / shares	3 Months Ended
	Sep. 30, 2016	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of Options Outstanding	3,800,000	3,800,000	2,270,000
Weighted Average Exercise Price of Outstanding Options (in Dollars per share)	$ 0.13	$ 0.13	$ 0.14
Number of Exercisable Options	3,195,000	3,070,000
Options at $0.08 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price of Options (in Dollars per share)	$ 0.08
Number of Options Outstanding	150,000
Weighted Average Remaining Contractual Life of Outstanding Options	5 years 2 months 1 day
Weighted Average Exercise Price of Outstanding Options (in Dollars per share)	$ 0.08
Number of Exercisable Options	150,000
Weighted Average Remaining Contractual Life of Exercisable Options	5 years 2 months 1 day
Options at $0.10 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price of Options (in Dollars per share)	$ 0.10
Number of Options Outstanding	2,200,000
Weighted Average Remaining Contractual Life of Outstanding Options	2 years 7 months 2 days
Weighted Average Exercise Price of Outstanding Options (in Dollars per share)	$ 0.10
Number of Exercisable Options	1,595,000
Weighted Average Remaining Contractual Life of Exercisable Options	2 years 7 months 2 days
Options at $0.17 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price of Options (in Dollars per share)	$ 0.17
Number of Options Outstanding	1,450,000
Weighted Average Remaining Contractual Life of Outstanding Options	4 years 2 months 1 day
Weighted Average Exercise Price of Outstanding Options (in Dollars per share)	$ 0.17
Number of Exercisable Options	1,450,000
Weighted Average Remaining Contractual Life of Exercisable Options	4 years 2 months 1 day

XML 40 R28.htm IDEA: XBRL DOCUMENT

NOTE 7 - LIQUIDITY (Details)	3 Months Ended
NOTE 7 - LIQUIDITY (Details)	Sep. 30, 2016 shares
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Shares Available for Issuance	7,488,713

EXCEL 41 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 43 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 38 162 1 false 16 0 false 4 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://www.amerityre.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Balance Sheets Sheet http://www.amerityre.com/role/ConsolidatedBalanceSheet Balance Sheets Statements 2 false false R3.htm 002 - Statement - Balance Sheets (Parentheticals) Sheet http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Statements of Operations (Unaudited) Sheet http://www.amerityre.com/role/ConsolidatedIncomeStatement Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Statements of Cash Flows (Unaudited) Sheet http://www.amerityre.com/role/ConsolidatedCashFlow Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION Sheet http://www.amerityre.com/role/NOTE1BASISOFFINANCIALSTATEMENTPRESENTATION NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION Notes 6 false false R7.htm 006 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 007 - Disclosure - NOTE 3 - INVENTORY Sheet http://www.amerityre.com/role/NOTE3INVENTORY NOTE 3 - INVENTORY Notes 8 false false R9.htm 008 - Disclosure - NOTE 4 - DEBT Sheet http://www.amerityre.com/role/NOTE4DEBT NOTE 4 - DEBT Notes 9 false false R10.htm 009 - Disclosure - NOTE 5 - CAPITAL LEASE Sheet http://www.amerityre.com/role/NOTE5CAPITALLEASE NOTE 5 - CAPITAL LEASE Notes 10 false false R11.htm 010 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS NOTE 6 - STOCK OPTIONS AND WARRANTS Notes 11 false false R12.htm 011 - Disclosure - NOTE 7 - LIQUIDITY Sheet http://www.amerityre.com/role/NOTE7LIQUIDITY NOTE 7 - LIQUIDITY Notes 12 false false R13.htm 012 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.amerityre.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies 13 false false R14.htm 013 - Disclosure - NOTE 3 - INVENTORY (Tables) Sheet http://www.amerityre.com/role/NOTE3INVENTORYTables NOTE 3 - INVENTORY (Tables) Tables http://www.amerityre.com/role/NOTE3INVENTORY 14 false false R15.htm 014 - Disclosure - NOTE 4 - DEBT (Tables) Sheet http://www.amerityre.com/role/NOTE4DEBTTables NOTE 4 - DEBT (Tables) Tables http://www.amerityre.com/role/NOTE4DEBT 15 false false R16.htm 015 - Disclosure - NOTE 5 - CAPITAL LEASE (Tables) Sheet http://www.amerityre.com/role/NOTE5CAPITALLEASETables NOTE 5 - CAPITAL LEASE (Tables) Tables http://www.amerityre.com/role/NOTE5CAPITALLEASE 16 false false R17.htm 016 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables) Tables http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS 17 false false R18.htm 017 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 18 false false R19.htm 018 - Disclosure - NOTE 3 - INVENTORY (Details) Sheet http://www.amerityre.com/role/NOTE3INVENTORYDetails NOTE 3 - INVENTORY (Details) Details http://www.amerityre.com/role/NOTE3INVENTORYTables 19 false false R20.htm 019 - Disclosure - NOTE 3 - INVENTORY (Details) - Schedule of Inventory Sheet http://www.amerityre.com/role/ScheduleofInventoryTable NOTE 3 - INVENTORY (Details) - Schedule of Inventory Details http://www.amerityre.com/role/NOTE3INVENTORYTables 20 false false R21.htm 020 - Disclosure - NOTE 4 - DEBT (Details) Sheet http://www.amerityre.com/role/NOTE4DEBTDetails NOTE 4 - DEBT (Details) Details http://www.amerityre.com/role/NOTE4DEBTTables 21 false false R22.htm 021 - Disclosure - NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt Sheet http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt Details http://www.amerityre.com/role/NOTE4DEBTTables 22 false false R23.htm 022 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) Sheet http://www.amerityre.com/role/NOTE5CAPITALLEASEDetails NOTE 5 - CAPITAL LEASE (Details) Details http://www.amerityre.com/role/NOTE5CAPITALLEASETables 23 false false R24.htm 023 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets Sheet http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets Details http://www.amerityre.com/role/NOTE5CAPITALLEASETables 24 false false R25.htm 024 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) Sheet http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 25 false false R26.htm 025 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity Sheet http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 26 false false R27.htm 026 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range Sheet http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range Details http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables 27 false false R28.htm 027 - Disclosure - NOTE 7 - LIQUIDITY (Details) Sheet http://www.amerityre.com/role/NOTE7LIQUIDITYDetails NOTE 7 - LIQUIDITY (Details) Details http://www.amerityre.com/role/NOTE7LIQUIDITY 28 false false All Reports Book All Reports amty-20160930.htm amty-20160930.xsd amty-20160930_cal.xml amty-20160930_def.xml amty-20160930_lab.xml amty-20160930_pre.xml ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm true true JSON 47 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "amty-20160930.htm": { "axisCustom": 0, "axisStandard": 5, "contextCount": 38, "dts": { "calculationLink": { "local": [ "amty-20160930_cal.xml" ] }, "definitionLink": { "local": [ "amty-20160930_def.xml" ] }, "inline": { "local": [ "amty-20160930.htm" ] }, "labelLink": { "local": [ "amty-20160930_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-doc-2016-01-31.xml", "http://xbrl.sec.gov/dei/2014/dei-doc-2014-01-31.xml" ] }, "presentationLink": { "local": [ "amty-20160930_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-ref-2016-01-31.xml", "http://xbrl.sec.gov/dei/2014/dei-ref-2014-01-31.xml" ] }, "schema": { "local": [ "amty-20160930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2016/elts/us-parts-codification-2016-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2016/elts/us-roles-2016-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd", "http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" ] } }, "elementCount": 235, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2016-01-31": 2, "http://www.amerityre.com/20160930": 1, "http://xbrl.sec.gov/dei/2014-01-31": 9, "total": 12 }, "keyCustom": 10, "keyStandard": 152, "memberCustom": 9, "memberStandard": 7, "nsprefix": "amty", "nsuri": "http://www.amerityre.com/20160930", "report": { "R1": { "firstAnchor": { "ancestors": [ "dei:AmendmentFlag", "span", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "true", "longName": "000 - Disclosure - Document And Entity Information", "role": "http://www.amerityre.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "dei:AmendmentFlag", "span", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - NOTE 5 - CAPITAL LEASE", "role": "http://www.amerityre.com/role/NOTE5CAPITALLEASE", "shortName": "NOTE 5 - CAPITAL LEASE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS", "role": "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - NOTE 7 - LIQUIDITY", "role": "http://www.amerityre.com/role/NOTE7LIQUIDITY", "shortName": "NOTE 7 - LIQUIDITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://www.amerityre.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "amty:ScheduleOfInventoryTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - NOTE 3 - INVENTORY (Tables)", "role": "http://www.amerityre.com/role/NOTE3INVENTORYTables", "shortName": "NOTE 3 - INVENTORY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "amty:ScheduleOfInventoryTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - NOTE 4 - DEBT (Tables)", "role": "http://www.amerityre.com/role/NOTE4DEBTTables", "shortName": "NOTE 4 - DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - NOTE 5 - CAPITAL LEASE (Tables)", "role": "http://www.amerityre.com/role/NOTE5CAPITALLEASETables", "shortName": "NOTE 5 - CAPITAL LEASE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCapitalLeasedAsssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables)", "role": "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "role": "http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails", "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PriorPeriodReclassificationAdjustment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - NOTE 3 - INVENTORY (Details)", "role": "http://www.amerityre.com/role/NOTE3INVENTORYDetails", "shortName": "NOTE 3 - INVENTORY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PriorPeriodReclassificationAdjustment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Balance Sheets", "role": "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "shortName": "Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - NOTE 3 - INVENTORY (Details) - Schedule of Inventory", "role": "http://www.amerityre.com/role/ScheduleofInventoryTable", "shortName": "NOTE 3 - INVENTORY (Details) - Schedule of Inventory", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c1_AsOf30Jun2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebtCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - NOTE 4 - DEBT (Details)", "role": "http://www.amerityre.com/role/NOTE4DEBTDetails", "shortName": "NOTE 4 - DEBT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c10_From1Jul2016To31Jul2016", "decimals": "0", "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentTransfersAndChanges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt", "role": "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable", "shortName": "NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalLeasesFutureMinimumPaymentsDue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - NOTE 5 - CAPITAL LEASE (Details)", "role": "http://www.amerityre.com/role/NOTE5CAPITALLEASEDetails", "shortName": "NOTE 5 - CAPITAL LEASE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "lang": null, "name": "us-gaap:CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets", "role": "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable", "shortName": "NOTE 5 - CAPITAL LEASE (Details) - Schedule of Capital Leased Assets", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details)", "role": "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c29_AsOf30Sep2013_ConvertibleDebtMember", "decimals": "0", "lang": null, "name": "us-gaap:ConvertibleNotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c1_AsOf30Jun2016", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity", "role": "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Stock Options, Activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "2", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range", "role": "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable", "shortName": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) - Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c32_AsOf30Sep2016_OptionsAt0.08Member", "decimals": "2", "lang": null, "name": "amty:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "INF", "first": true, "lang": null, "name": "amty:SharesAvailableForIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - NOTE 7 - LIQUIDITY (Details)", "role": "http://www.amerityre.com/role/NOTE7LIQUIDITYDetails", "shortName": "NOTE 7 - LIQUIDITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "INF", "first": true, "lang": null, "name": "amty:SharesAvailableForIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Balance Sheets (Parentheticals)", "role": "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c0_AsOf30Sep2016", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SalesRevenueNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Statements of Operations (Unaudited)", "role": "http://www.amerityre.com/role/ConsolidatedIncomeStatement", "shortName": "Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SalesRevenueNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Statements of Cash Flows (Unaudited)", "role": "http://www.amerityre.com/role/ConsolidatedCashFlow", "shortName": "Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "005 - Disclosure - NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION", "role": "http://www.amerityre.com/role/NOTE1BASISOFFINANCIALSTATEMENTPRESENTATION", "shortName": "NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES", "shortName": "NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - NOTE 3 - INVENTORY", "role": "http://www.amerityre.com/role/NOTE3INVENTORY", "shortName": "NOTE 3 - INVENTORY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - NOTE 4 - DEBT", "role": "http://www.amerityre.com/role/NOTE4DEBT", "shortName": "NOTE 4 - DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "contextRef": "c2_From1Jul2016To30Sep2016", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 16, "tag": { "amty_AuditCommitteeChairMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information about related party.", "label": "Audit Committee Chair [Member]", "terseLabel": "Audit Committee Chair [Member]" } } }, "localname": "AuditCommitteeChairMember", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_BoardMemberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information about related parties.", "label": "Board Member [Member]", "terseLabel": "Board member [Member]" } } }, "localname": "BoardMemberMember", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_BoardMembersAndAuditoCommitteChairMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information related to board members and audit committee chair.", "label": "Board Members And Audito Committe Chair [Member]", "terseLabel": "Board Members and Audito Committe Chair [Member]" } } }, "localname": "BoardMembersAndAuditoCommitteChairMember", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_ClassOfWarrantOrRightsGranted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Aggregate amount of each class of warrants or rights granted.", "label": "Class of Warrant or Rights, Granted" } } }, "localname": "ClassOfWarrantOrRightsGranted", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "sharesItemType" }, "amty_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.amerityre.com/20160930", "xbrltype": "stringItemType" }, "amty_LongTermLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "LONG-TERM LIABILITIES" } } }, "localname": "LongTermLiabilitiesAbstract", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "amty_MonthlyHealthInsuranceReimbursement": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of monthly health insurance reimbursement.", "label": "Monthly Health Insurance Reimbursement" } } }, "localname": "MonthlyHealthInsuranceReimbursement", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "amty_NOTE4DEBTDetailsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 4 - DEBT (Details) [Line Items]" } } }, "localname": "NOTE4DEBTDetailsLineItems", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE4DEBTDetailsScheduleofMaturitiesofLongtermDebtLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt [Line Items]" } } }, "localname": "NOTE4DEBTDetailsScheduleofMaturitiesofLongtermDebtLineItems", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "stringItemType" }, "amty_NOTE4DEBTDetailsScheduleofMaturitiesofLongtermDebtTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 4 - DEBT (Details) - Schedule of Maturities of Long-term Debt [Table]" } } }, "localname": "NOTE4DEBTDetailsScheduleofMaturitiesofLongtermDebtTable", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "stringItemType" }, "amty_NOTE4DEBTDetailsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 4 - DEBT (Details) [Table]" } } }, "localname": "NOTE4DEBTDetailsTable", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE6STOCKOPTIONSANDWARRANTSDetailsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Line Items]" } } }, "localname": "NOTE6STOCKOPTIONSANDWARRANTSDetailsLineItems", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "amty_NOTE6STOCKOPTIONSANDWARRANTSDetailsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NOTE 6 - STOCK OPTIONS AND WARRANTS (Details) [Table]" } } }, "localname": "NOTE6STOCKOPTIONSANDWARRANTSDetailsTable", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "amty_OptionsAt0.08Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of equity transaction.", "label": "Options At 0. 08 [Member]", "terseLabel": "Options at $0.08 [Member]" } } }, "localname": "OptionsAt0.08Member", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "domainItemType" }, "amty_OptionsAt0.10Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of equity transaction.", "label": "Options At 0. 10 [Member]", "terseLabel": "Options at $0.10 [Member]" } } }, "localname": "OptionsAt0.10Member", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "domainItemType" }, "amty_OptionsAt017Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of equity transaction.", "label": "Options At 017 [Member]", "terseLabel": "Options at $0.17 [Member]" } } }, "localname": "OptionsAt017Member", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "domainItemType" }, "amty_OptionsGrantedDecember1_2015Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Award date.", "label": "Options Granted December 1_ 2015 [Member]", "terseLabel": "Options Granted December 1, 2015 [Member]" } } }, "localname": "OptionsGrantedDecember1_2015Member", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_OptionsGrantedJanuary19_2016Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Award date.", "label": "Options Granted January 19_ 2016 [Member]", "terseLabel": "Options Granted January 19, 2016 [Member]" } } }, "localname": "OptionsGrantedJanuary19_2016Member", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_OptionsGrantedOctober2015Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Award date.", "label": "Options Granted October 2015 [Member]", "terseLabel": "Options Granted October 2015 [Member]" } } }, "localname": "OptionsGrantedOctober2015Member", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "amty_SalesCommissionPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of sales commission outlined in commission agreement.", "label": "Sales Commission, Percentage" } } }, "localname": "SalesCommissionPercentage", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "percentItemType" }, "amty_ScheduleOfCapitalLeasedAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Capital Leased Assets [Abstract]" } } }, "localname": "ScheduleOfCapitalLeasedAssetsAbstract", "nsuri": "http://www.amerityre.com/20160930", "xbrltype": "stringItemType" }, "amty_ScheduleOfInventoryAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Inventory [Abstract]" } } }, "localname": "ScheduleOfInventoryAbstract", "nsuri": "http://www.amerityre.com/20160930", "xbrltype": "stringItemType" }, "amty_ScheduleOfInventoryTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of inventory, current and noncurrent.", "label": "Schedule of Inventory [Table Text Block]" } } }, "localname": "ScheduleOfInventoryTableTextBlock", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE3INVENTORYTables" ], "xbrltype": "textBlockItemType" }, "amty_ScheduleOfMaturitiesOfLongTermDebtAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Maturities of Long-term Debt [Abstract]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtAbstract", "nsuri": "http://www.amerityre.com/20160930", "xbrltype": "stringItemType" }, "amty_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Abstract]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAbstract", "nsuri": "http://www.amerityre.com/20160930", "xbrltype": "stringItemType" }, "amty_ScheduleOfShareBasedCompensationStockOptionsActivityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Schedule of Share-based Compensation, Stock Options, Activity [Abstract]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityAbstract", "nsuri": "http://www.amerityre.com/20160930", "xbrltype": "stringItemType" }, "amty_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The exercise price of the options granted.", "label": "Exercise Price of Options (in Dollars per share)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisePrice", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "perShareItemType" }, "amty_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the equity-based award vest, in CCYY-MM-DD format.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingDate", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "dateItemType" }, "amty_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationDate2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the equity-based award expires.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationDate2", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationDate2", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "amty_SharebasedCompensationArrangementBySharebasedPaymentAwardVestingDate2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the equity-based award vest.", "label": "SharebasedCompensationArrangementBySharebasedPaymentAwardVestingDate2", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Vesting Date" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardVestingDate2", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "amty_SharesAvailableForIssuance": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares available for issuance.", "label": "Shares Available for Issuance" } } }, "localname": "SharesAvailableForIssuance", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE7LIQUIDITYDetails" ], "xbrltype": "sharesItemType" }, "amty_WarrantsTermOfWarrants": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Term of warrants exercisable in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Warrants, Term of Warrants" } } }, "localname": "WarrantsTermOfWarrants", "nsuri": "http://www.amerityre.com/20160930", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "durationItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "If the value is true, then the document is an amendment to previously-filed/accepted document.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word \"Other\".", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r162" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate \"Yes\" or \"No\" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityFilerCategory": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r162" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate \"Yes\" or \"No\" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate \"Yes\" or \"No\" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2014-01-31", "presentation": [ "http://www.amerityre.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r32", "r38" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.", "label": "Accounts receivable - net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r42", "r101" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less - accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r33" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to reconcile net loss to net cash used by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r111", "r123", "r125" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.", "label": "Allocated Share-based Compensation Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the allowance for doubtful accounts.", "label": "Allowance for Doubtful Accounts Receivable, Period Increase (Decrease)", "terseLabel": "Change in allowance for bad debt expense (recovery)" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r0", "r3", "r4", "r91" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r147", "r154" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r18", "r19", "r56" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateAxis": { "auth_ref": [ "r112", "r124" ], "lang": { "en-US": { "role": { "documentation": "Information by date or year of grant, pertaining to equity-based compensation arrangements.", "label": "Award Date [Axis]" } } }, "localname": "AwardDateAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardDateDomain": { "auth_ref": [ "r112", "r124" ], "lang": { "en-US": { "role": { "documentation": "Date or year of grant of equity-based compensation.", "label": "Award Date [Domain]" } } }, "localname": "AwardDateDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalLeaseObligationsCurrent": { "auth_ref": [ "r27", "r135", "r137" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.", "label": "Current portion of lease liability" } } }, "localname": "CapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeaseObligationsIncurred": { "auth_ref": [ "r77", "r78" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase during the period in capital lease obligations due to entering into new capital leases.", "label": "Capitalized lease" } } }, "localname": "CapitalLeaseObligationsIncurred", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeaseObligationsNoncurrent": { "auth_ref": [ "r50", "r135", "r137" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.", "label": "Long-term lease liability" } } }, "localname": "CapitalLeaseObligationsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDue": { "auth_ref": [ "r137" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 1.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases.", "label": "Capital Leases, Future Minimum Payments Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE5CAPITALLEASEDetails", "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r137" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2021" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r137" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 4.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2020" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r137" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 3.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2019" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r137" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 2.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2018" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsExecutoryCosts": { "auth_ref": [ "r137" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 2.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amounts to be paid by lessee to lessor for maintenance, insurance, and tax expenses related to the leased asset.", "label": "Less: executory costs" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsExecutoryCosts", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments": { "auth_ref": [ "r137" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 2.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount necessary to reduce net minimum lease payments to present value for capital leases.", "label": "Less: amount representing interest" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1": { "auth_ref": [ "r137" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 1.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases net of executory costs, which include amounts paid by the lessee to the lessor for insurance, maintenance and taxes.", "label": "Capital Leases, Future Minimum Payments, Net Minimum Payments", "totalLabel": "Net minimum lease payments" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments": { "auth_ref": [ "r137" ], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of minimum lease payments for capital leases net of executory costs, including amounts paid by the lessee to the lessor for insurance, maintenance and taxes.", "label": "Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments", "totalLabel": "Present value of net minimum payments" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable": { "order": 1.0, "parentTag": "us-gaap_CapitalLeasesFutureMinimumPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of minimum lease payments for capital leases due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "2017" } } }, "localname": "CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofCapitalLeasedAssetsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation": { "auth_ref": [ "r133", "r134" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total charge for the use of long-lived depreciable assets subject to a lease meeting the criteria for capitalization.", "label": "Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation" } } }, "localname": "CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE5CAPITALLEASEDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r160" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r1", "r2", "r16", "r41", "r75" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "periodEndLabel": "CASH AT END OF PERIOD", "periodStartLabel": "CASH AT BEGINNING OF PERIOD" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [ "r67", "r128" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "NET DECREASE IN CASH" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChiefExecutiveOfficerMember": { "auth_ref": [ "r142" ], "lang": { "en-US": { "role": { "documentation": "Highest ranking executive officer, who has ultimate managerial responsibility for the entity and who reports to the board of directors. In addition, the chief executive officer (CEO) may also be the chairman of the board or president.", "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChiefFinancialOfficerMember": { "auth_ref": [ "r142" ], "lang": { "en-US": { "role": { "documentation": "Senior executive officer responsible for overseeing the financial activities of the entity.", "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r85" ], "lang": { "en-US": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r31" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r31", "r108" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesSubscriptions": { "auth_ref": [ "r31", "r107" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Stock payable" } } }, "localname": "CommonStockSharesSubscriptions", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r31" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock: 75,000,000 shares authorized of $0.001 par value, 42,325,287 and 42,175,287 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConstructionInProgressGross": { "auth_ref": [ "r100" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in progress" } } }, "localname": "ConstructionInProgressGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r106" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r47" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Current" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r60" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "COST OF REVENUES" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.", "label": "Debt and Capital Leases Disclosures [Text Block]" } } }, "localname": "DebtAndCapitalLeasesDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE5CAPITALLEASE" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r45", "r109" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBT" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r130", "r132" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r49" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r50", "r153" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Debt Instrument, Periodic Payment" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DepositsAssetsNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.", "label": "Deposits" } } }, "localname": "DepositsAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r73" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisclosureTextBlockAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure Text Block [Abstract]" } } }, "localname": "DisclosureTextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisclosureTextBlockSupplementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure Text Block Supplement [Abstract]" } } }, "localname": "DisclosureTextBlockSupplementAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r110", "r152" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Accrued preferred stock dividends" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStockCash": { "auth_ref": [ "r110", "r152" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash.", "label": "Dividends, Preferred Stock, Cash", "negatedLabel": "Preferred Stock Dividend" } } }, "localname": "DividendsPreferredStockCash", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "BASIC AND DILUTED LOSS PER SHARE (in Dollars per share)" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r82", "r91", "r92", "r93" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesGross": { "auth_ref": [ "r100" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r61" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r59" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "GROSS PROFIT" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r69", "r76" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r72" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r72" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r72" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory and any change in inventory reserve" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r72" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r98", "r99" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Patents and trademarks - net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r129", "r131", "r151" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r68", "r76" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid for interest during the period.", "label": "Interest paid", "terseLabel": "Interest Paid" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r21", "r55" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE3INVENTORY" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r51" ], "calculation": { "http://www.amerityre.com/role/ScheduleofInventoryTable": { "order": 2.0, "parentTag": "us-gaap_OtherInventoryNetOfReserves", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished Goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r17", "r53", "r96" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory - net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNoncurrent": { "auth_ref": [ "r54" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.", "label": "Non-current inventory" } } }, "localname": "InventoryNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r52" ], "calculation": { "http://www.amerityre.com/role/ScheduleofInventoryTable": { "order": 1.0, "parentTag": "us-gaap_OtherInventoryNetOfReserves", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw Materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r53", "r87", "r96", "r97" ], "calculation": { "http://www.amerityre.com/role/ScheduleofInventoryTable": { "order": 3.0, "parentTag": "us-gaap_OtherInventoryNetOfReserves", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Inventory reserve" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r62" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r73" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Stock based compensation" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsGross": { "auth_ref": [ "r20", "r100" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.", "label": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r46" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r37", "r149", "r157" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "LIABILITIES AND STOCKHOLDER\u2019S EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r22", "r23", "r24", "r28", "r29" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total Long Term Liability" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r28", "r148", "r155" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Current portion of long-term debt", "terseLabel": "Long-term Debt, Current Maturities" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturingInYearsFourAndFive": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth and fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "3 to 5 years" } } }, "localname": "LongTermDebtMaturingInYearsFourAndFive", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturingInYearsTwoAndThree": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second and third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "1 to 3 years" } } }, "localname": "LongTermDebtMaturingInYearsTwoAndThree", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "auth_ref": [ "r86", "r104" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "After 5 years" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r86", "r104" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Less than 1 year" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term debt", "terseLabel": "Long-term Debt, Excluding Current Maturities" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails", "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r50", "r105" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails", "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r20", "r100" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r67", "r71" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Used by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r67", "r71" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used by Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r67", "r70", "r74" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used by Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r8", "r9", "r57", "r74", "r92", "r150", "r159" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "NET LOSS" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r88" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r63" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other (Expense)/Income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OTHER (EXPENSE)/INCOME" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r77", "r78", "r79" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Purchase of fixed assets through debt" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableOtherPayablesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "Notes Payable, Other Payables [Member]" } } }, "localname": "NotesPayableOtherPayablesMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableToBanksMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A written promise to pay a note to a bank.", "label": "Notes Payable to Banks [Member]" } } }, "localname": "NotesPayableToBanksMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails", "http://www.amerityre.com/role/ScheduleofMaturitiesofLongtermDebtTable" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "EXPENSES" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "LOSS FROM OPERATIONS" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r12", "r13", "r82", "r94", "r127" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE1BASISOFFINANCIALSTATEMENTPRESENTATION" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OTHER ASSETS" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "totalLabel": "Total Other Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInventoryNetOfReserves": { "auth_ref": [ "r55", "r97" ], "calculation": { "http://www.amerityre.com/role/ScheduleofInventoryTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after of valuation reserves and allowances, of inventory, classified as other, expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Other Inventory, Net of Reserves", "totalLabel": "Inventory \u2013 net (current and long term)" } } }, "localname": "OtherInventoryNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationReceived1": { "auth_ref": [ "r77", "r78", "r79" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.", "label": "Write off of previous reserved forklift tires" } } }, "localname": "OtherSignificantNoncashTransactionValueOfConsiderationReceived1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r5", "r65" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Preferred stock dividends" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r6", "r64" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r30" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r30" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r18", "r39", "r40" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of a reclassification adjustment made to prior period financial statement amounts.", "label": "Prior Period Reclassification Adjustment" } } }, "localname": "PriorPeriodReclassificationAdjustment", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE3INVENTORYDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r13" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.", "label": "Reclassification, Policy [Policy Text Block]" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r25", "r26", "r102", "r158" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Total Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentNetAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentOther": { "auth_ref": [ "r102" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Molds and models" } } }, "localname": "PropertyPlantAndEquipmentOther", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTransfersAndChanges": { "auth_ref": [ "r103" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Transfers and Changes" } } }, "localname": "PropertyPlantAndEquipmentTransfersAndChanges", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by range, including, but not limited to, upper and lower bounds.", "label": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extent of variation, for example, but not limited to, upper and lower bounds.", "label": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r7", "r10", "r11", "r138", "r139", "r140" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r141", "r143", "r144", "r145", "r146" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r5", "r66" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Repayments of Convertible Debt", "negatedLabel": "Payments on notes payable" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": { "auth_ref": [ "r66" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).", "label": "Repayments of Long-term Capital Lease Obligations", "negatedLabel": "Payment on lease liability" } } }, "localname": "RepaymentsOfLongTermCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r126", "r161" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r34", "r110", "r156" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNet": { "auth_ref": [ "r58" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.", "label": "NET SALES" } } }, "localname": "SalesRevenueNet", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Any scenario, that is, the particular reporting scenario is left unspecified. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures." } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfCapitalLeasedAsssetsTableTextBlock": { "auth_ref": [ "r136" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of long-lived, depreciable assets that are subject to a lease meeting the criteria for capitalization and are used in the normal conduct of business to produce goods and services. Examples may include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Schedule of Capital Leased Assets [Table Text Block]" } } }, "localname": "ScheduleOfCapitalLeasedAsssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE5CAPITALLEASETables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r104" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE4DEBTTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.", "label": "Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.amerityre.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r113" ], "lang": { "en-US": { "role": { "documentation": "Date the equity-based award expires, in CCYY-MM-DD format.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r117" ], "lang": { "en-US": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number of Exercisable Options", "periodEndLabel": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r117" ], "lang": { "en-US": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r119" ], "lang": { "en-US": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Expired/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r119" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "negatedTerseLabel": "Expired/Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Granted", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Outstanding end of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r116", "r124" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Number of Options Outstanding", "periodEndLabel": "Outstanding end of period", "periodStartLabel": "Outstanding beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r115" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Weighted Average Exercise Price of Outstanding Options (in Dollars per share)", "periodEndLabel": "Outstanding end of period", "periodStartLabel": "Outstanding beginning of period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable", "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r121" ], "lang": { "en-US": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r122" ], "lang": { "en-US": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTSDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r124" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Life of Exercisable Options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r120" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Life of Outstanding Options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationSharesAuthorizedunderStockOptionPlansbyExercisePriceRangeTable" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for accounts comprising shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income, and compensation-related costs for equity-based compensation. Includes, but is not limited to, disclosure of policies, compensation plan details, equity-based arrangements to obtain goods and services, deferred compensation arrangements, and employee stock purchase plan details.", "label": "Shareholders' Equity and Share-based Payments [Text Block]" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE6STOCKOPTIONSANDWARRANTS" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r80", "r81", "r82", "r83", "r84" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE2SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementScenarioAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by scenario to be reported. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.", "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet", "http://www.amerityre.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.amerityre.com/role/ConsolidatedCashFlow", "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r77", "r78", "r79" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Issuance of stock for stock payable" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r30", "r31", "r108", "r110", "r118" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ScheduleofSharebasedCompensationStockOptionsActivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r31", "r35", "r36", "r95" ], "calculation": { "http://www.amerityre.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Stockholders\u2019 Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r14", "r15" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Substantial Doubt about Going Concern [Text Block]" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/NOTE7LIQUIDITY" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "NON-CASH FINANCING ACTIVITIES" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r89", "r90" ], "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in Shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2016-01-31", "presentation": [ "http://www.amerityre.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Glossary": "Antidilution", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6505113" }, "r1": { "Glossary": "Cash", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6506951" }, "r10": { "Glossary": "Principal Owners", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6521851" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=64862545&loc=d3e2921-110230" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=28183637&loc=d3e4852-112606" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644" }, "r11": { "Glossary": "Related Parties", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=16382449" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=35735333&loc=d3e288-107754" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=64809438&loc=d3e5614-111684" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930785&loc=d3e28555-108399" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 2)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=6455314&loc=d3e45014-112735" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737" }, "r138": { "Glossary": "Affiliate", "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6504562" }, "r139": { "Glossary": "Control", "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6508935" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=64819266&loc=SL51888443-203568" }, "r140": { "Glossary": "Immediate Family", "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6515043" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=64819266&loc=SL51888449-203568" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "225", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r162": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12b", "Subsection": "1" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765" }, "r2": { "Glossary": "Cash Equivalents", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6507016" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r3": { "Glossary": "Contingent Stock Agreement", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6508534" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r4": { "Glossary": "Diluted Earnings Per Share", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6510752" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20,22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r5": { "Glossary": "Financing Activities", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6513228" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(d))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r6": { "Glossary": "Investing Activities", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6516133" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "225", "URI": "http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585" }, "r7": { "Glossary": "Management", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=6517382" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586" }, "r8": { "Glossary": "Net Income", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=51831255" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18726-107790" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18743-107790" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18780-107790" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18854-107790" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=68058157&loc=d3e18861-107790" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(i)(4))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=64863997&loc=d3e1377-109256" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256" }, "r9": { "Glossary": "Other Comprehensive Income", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "http://asc.fasb.org/extlink&oid=51831270" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" } }, "version": "2.0" } ZIP 48 0001185185-16-005644-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001185185-16-005644-xbrl.zip M4$L#!!0 ( !=,9$GL[F2TR,#$V,#DS,"YH M=&WL?6EWVSC2[O?W5^!US\Q-GT,YVI2>F>OE_Z0"1D<4*1 M&BYVW+_^5@$D189CPP^L^"1\#=\/_:\Z8?W[Y^>GLXUN!2>Z##7]AV-N?@!*12" MQU\Z#!_^@5P[!KFS'TFQ2HJM#Y7BAUJ9M*\&I%PLU<7E8P\�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end